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ABSTRACT OF THE DISSERTATION 
Negative Regulation of the Hippo Pathway by the Ajuba LIM Proteins 
By 
Radhika Jagannathan 
Doctor of Philosophy in Biology & Biomedical Sciences 
Molecular Cell Biology 
Washington University in St. Louis, 2014 
Professor Gregory D. Longmore, Chairperson 
The highly conserved Hippo kinase cascade is critical for both regulation of organ size in 
development and tumor suppression. Several mechanisms, such as cell-cell contact in 
vitro and organ size in vivo, have been implicated in the activation of the Hippo pathway, 
leading to inactivation of the YAP/TAZ transcriptional co-activators and growth arrest. 
Previous work from our lab has identified the Ajuba LIM proteins as novel negative 
regulators of the Hippo pathway in both Drosophila and mammals. However, the 
mechanism by which the Ajuba LIM proteins prevent Hippo pathway activity is not 
known. Using contact inhibition of proliferation as a functional assay of Hippo pathway 
activity, we find that the Ajuba LIM proteins bind to the Ndr-kinase Lats1/2 and inhibit 
Hippo pathway-mediated inactivation of YAP only in low density, proliferating cells, 
suggesting that the Ajuba LIM proteins function to keep the Hippo pathway off in 
contexts where cell proliferation is needed, but are unable to prevent activation of the 
pathway by signals such as cell density.  We demonstrate that the Ajuba LIM proteins 
enhance association of the core kinase complex, and, using a panel of LIM domain 
mutants of the Ajuba LIM protein, LIMD1, identify the domains required for 
sequestering active Lats2 in the core kinase complex.  Using Drosophila wing size as an 
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in vivo read-out of Hippo activity, we find that only the domain mutants that increase 
complex association suppress Hippo-mediated YAP inactivation. We also determine the 
role of subcellular localization in Ajuba LIM-mediated inhibition of the Hippo pathway.  
It has previously been shown that targeting the complex to the plasma membrane, using a 
membrane-targeted Mob1, can lead to its activation; interestingly, we find that LIMD1 is 
unable to associate with or enhance the association of this membrane-targeted complex.  
Conversely, targeting LIMD1 to the plasma membrane also abrogates its ability to bind 
to, and enhance the association of, the cytoplasmic core kinase complex. Given that 
LIMD1 and the Hippo complex are both recruited to the plasma membrane in high 
density, growth-arrested cells, these results provide a model for Ajuba LIM-mediated 
inhibition of Hippo pathway signaling, in which the Ajuba LIM proteins physically 
interact with the core kinase complex in the cytoplasm of low-density, proliferating cells, 
thereby preventing inactivation of YAP and premature growth-arrest. 
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Chapter 1 
Introduction 
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The LIM domain 
 LIN-11-Isl1-MEC-3 (LIM) domains are cysteine-rich, double zinc finger motifs found in 
a wide variety of eukaryotic proteins, encompassing a diversity of biological functions (Kadrmas 
and Beckerle, 2004). The LIM consensus sequence is characterized by eight highly conserved 
zinc-binding residues, mostly cysteine and histidine (Fig. 1). Variability within the remaining 
~45 residues helps confer functional specificity between LIM domains.  
 Unlike classical C2H2 zinc finger domains, LIM domains do not seem to confer DNA 
binding capability, although several LIM domain-containing proteins have been found in the 
nucleus and regulate gene transcription (Kadrmas and Beckerle, 2004; Matthews and Sunde, 
2002). Instead, LIM domains are primarily protein-protein interaction modules, which can act as 
adaptors or scaffolds for a variety of binding partners (Kadrmas and Beckerle, 2004; Matthews 
and Sunde, 2002). The diversity of LIM domain binding partners largely underlies the variety of 
biological processes in which LIM domain-containing proteins are implicated (Kadrmas and 
Beckerle, 2004).  
 One other characteristic of many of the LIM proteins is their ability to shuttle between 
subcellular compartments. While a few, such as LIM homeodomain (LHX) and nuclear LIM 
only (LMO) are found almost exclusively in the nucleus, most other LIM proteins are capable of 
shuttling between the nucleus and the cytoplasm (Kadrmas and Beckerle, 2004). As such, LIM 
proteins may be well-suited as messengers to convey signals between different cellular 
compartments. 
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The Ajuba/Zyxin family of LIM proteins 
 The Ajuba/Zyxin family of LIM proteins consists of six mammalian members divided 
into two subfamilies: the Zyxin subfamily, including Zyxin, lipoma preferred partner (LPP), and 
thyroid hormone interacting protein 6 (Trip6); and the Ajuba subfamily with Ajuba, LIM 
domain-containing protein 1 (LIMD1), and Wilms tumor 1 interacting protein (WTIP) (Goyal et 
al., 1999; Kiss et al., 1999; Macalma et al., 1996; Petit et al., 1996; Srichai et al., 2004; Wang et 
al., 1999) (Fig. 2B). These molecules are characterized by the presence of three tandem LIM 
domains in the C-terminus (known as the LIM region), with a variable, proline-rich N-terminal 
preLIM domain (Hervy et al., 2006) (Fig. 2A). In addition, consistent with their ability to shuttle 
between the nucleus and the cytoplasm, the Ajuba Zyxin proteins contain a nuclear export 
sequence (NES) within the preLIM domain (Hervy et al., 2006; Kanungo et al., 2000; Nix and 
Beckerle, 1997; Sharp et al., 2004; Srichai et al., 2004; Wang and Gilmore, 2001) (Fig. 2A). 
While the two subfamilies share many characteristics, including association with various 
junctional and cytoskeletal components, functionally, the Zyxin and Ajuba subfamilies appear to 
be distinct.  
Cellular processes of the Zyxin LIM proteins 
The Zyxin family proteins localize to focal adhesions, regulate cell motility, and can 
associate with the actin cytoskeleton (Bai et al., 2007; Crawford et al., 1992; Drees et al., 1999; 
Lin and Lin, 2011; Reinhard et al., 1999; Wang et al., 1999). They associate with α-actinin, 
which promotes the localization of LPP to points of cell-cell contact, and promotes Zyxin-
mediated cell migration (Drees et al., 1999; Hansen and Beckerle, 2008). In addition, Zyxin 
regulates actin cytoskeletal dynamics by recruiting members of the Ena/VASP family of actin 
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polymerization regulators (Drees et al., 2000; Renfranz and Beckerle, 2002). The Zyxin LIM 
proteins can also localize to the nucleus, and there is some evidence that they promote gene 
transcription. Zyxin can associate with p130Cas and the Cas-interacting transcription factor, 
ZNF384, and may link p130Cas to ZNF384 to promote gene expression (Janssen and Marynen, 
2006; Yi et al., 2002), while LPP is a transcriptional co-activator of the ETS domain 
transcription factor PEA3 (Guo et al., 2006). In addition, a transcriptional variant of Trip6 
lacking the N-terminal region of the full-length protein, nTrip6, accumulates in the nucleus and 
can associate with the AP-1 and NF-κB promoters (Kassel et al., 2004).  
Cellular processes of the Ajuba LIM proteins 
 Ajuba, of the Ajuba LIM protein family, has also been shown to localize to focal 
adhesions, but unlike the Zyxin LIM proteins, it does not associate with α-actinin, and does not 
affect cell-matrix adhesion (Pratt et al., 2005). Instead, Ajuba promotes cell migration via an 
association with p130Cas and subsequent activation of Rac at the leading edge (Pratt et al., 
2005). In addition, Ajuba is recruited to, and stabilizes, adherens junctions via an association 
with α-catenin (Marie et al., 2003). Furthermore, at nascent junctions, Ajuba activates Rac to 
promote junctional maturation and cell-cell adhesion maintenance (Nola et al., 2011). Ajuba is 
also able to bind directly to F-actin, suggesting that the Ajuba LIM proteins could function to 
link α-catenin with the actin cytoskeleton, and thereby promote junctional maturation and 
epithelial polarity (Marie et al., 2003; Nelson, 2003; Nola et al., 2011).  
Like the Zyxin LIM proteins, the Ajuba LIM proteins also shuttle into the nucleus. 
Nuclear Ajuba can promote embryonal cell differentiation in a Jnk-mediated fashion (Kanungo 
et al., 2000). Also, Ajuba is a Snail/Slug co-repressor and is important for the process of 
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epithelial-mesenchymal transition (EMT) (Hou et al., 2008; Langer et al., 2008). LIMD1, 
another Ajuba LIM protein, can bind to pRB in the nucleus to enhance its repression of E2F-
driven transcription (Sharp et al., 2004).  
 The three Ajuba LIM proteins, Ajuba, LIMD1, and WTIP, are highly homologous and 
thought to function largely redundantly (Das Thakur et al., 2010). Loss of Ajuba or LIMD1 
alone, for example, results in a mild delay in cell-cell junction maturation, but loss of both Ajuba 
and LIMD1 together dramatically impairs cell-cell adhesion (Das Thakur, 2010). As such, 
analysis of the in vivo function of the Ajuba LIM proteins in mammals has been difficult. 
However, recently, we identified a Drosophila homolog of the Ajuba LIM proteins, djub, which 
regulates cell proliferation and apoptosis via the Hippo kinase cascade (Das Thakur et al., 2010). 
The Hippo kinase cascade responds to a variety of extracellular and intracellular growth-
regulatory signals. The Ajuba LIM proteins, as molecules that can shuttle between different 
subcellular compartments, are prime candidates to transduce these diverse signals to intracellular 
effectors.  
The Hippo pathway 
The Hippo pathway is an evolutionarily conserved kinase cascade that regulates cell 
proliferation and apoptosis. The components of the pathway were initially identified in 
Drosophila, in mutagenesis screens to identify putative tumor suppressors and regulators of 
tissue growth (Harvey et al., 2003; Justice et al., 1995; Tapon et al., 2002; Udan et al., 2003; Wu 
et al., 2003; Xu et al., 1995). The first identified component of the Hippo pathway was the warts 
(wts) gene, a serine/threonine protein kinase of the nuclear Dbf2-related (NDR)-family (Justice 
et al., 1995; Xu et al., 1995). Loss of wts causes dramatic tissue overgrowth with a disruption of 
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tissue architecture (Justice et al., 1995; Xu et al., 1995). Similarly, loss of the Ste20-family 
kinase, hippo (hpo) and the WW domain-containing protein, salvador (sav) or shar-pei, also 
results in an increase in organ size, due to increased cell proliferation and a decrease in apoptosis 
(Fig. 3B-B’) (Harvey et al., 2003; Kango-Singh et al., 2002; Tapon et al., 2002; Udan et al., 
2003; Wu et al., 2003). Interestingly, the Wts kinase shares significant sequence homology with 
the mammalian tumor suppressors Lats1/2, and LATS1 overexpression can functionally rescue 
deficiency of wts in Drosophila tissues (Hori et al., 2000; St John et al., 1999; Tao et al., 1999; 
Yabuta et al., 2000). Lats1 null mice develop soft tissue sarcomas (St John et al., 1999), while 
Lats2 null mice are embryonic lethal (McPherson et al., 2004). LATS2 is located at chromosome 
13q11-12, a hot-spot for loss of heterozygosity in many cancers (Yabuta et al., 2000), and has 
been shown to be mutated or down-regulated in lung cancers (Sasaki et al., 2010; Strazisar et al., 
2009).  Conditional deletion of Mst1/2, the mammalian Hpo homolog, in the mouse liver leads to 
organ overgrowth and hepatocellular carcinoma development (Fig. 3D-D’) (Lu et al., 2010; Song 
et al., 2010; Zhou et al., 2009), while mice homozygous null for the Sav homolog, WW45, suffer 
perinatal lethality due to epithelial hyperplasia (Lee et al., 2008).  
Fundamentally, the Hippo pathway consists of a core kinase complex, composed of the 
aforementioned Mst/Hpo, Lats/Wts, WW45/Sav, and a fourth component, the Mps one binder 
proteins, Mob1 (in mammals) or mats (in flies) (Lai et al., 2005) (Fig. 4).  In response to a 
variety of signals, including organ growth in vivo and cell-cell contact in vitro, the Hippo core 
kinase complex is activated. First, Mst/Hpo autophosphorylates, in a process enhanced by 
binding to WW45/Sav (Chan et al., 2005; Guo et al., 2007; Lee et al., 2008; Pantalacci et al., 
2003), and then recruits and phosphorylates Mob1/Mats (Bao et al., 2009). This in turn enhances 
the binding of Lats/Wts to the complex, leading to Lats/Wts activation by Mst/Hpo-mediated 
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phosphorylation, as well as autophosphorylation (Bao et al., 2009; Chan et al., 2005; Visser and 
Yang, 2010). The active Lats/Wts, in turn, phosphorylates the transcriptional co-activators YAP 
and TAZ (in mammals) or Yorkie (Yki) (in flies), leading to YAP/TAZ/Yki inactivation by 
sequestration in the cytosol or by proteasomal degradation (Hao et al., 2008; Huang et al., 2005; 
Liu et al., 2010; Zhao et al., 2010b; Zhao et al., 2007). 
YAP/Yki-mediated gene transcription 
YAP/TAZ and Yki are transcriptional co-activators that bind to the TEAD/TEF family of 
transcription factors (Vassilev et al., 2001; Wu et al., 2008). Overexpression of Yap in mouse 
liver, or yki in Drosophila imaginal discs, leads to massive tissue overgrowth, similar to the 
phenotypes associated with loss of the Hippo pathway core complex components (Dong et al., 
2007; Huang et al., 2005) (Fig. 3A, C), indicating that YAP and Yki promote tissue growth. In 
addition, YAP upregulation and nuclear localization has been associated with poor prognosis in a 
number of human cancers (Wang et al., 2010; Xu et al., 2009; Yeo et al., 2012). 
Mammals express four TEAD family transcription factors, TEAD1-4, which display 
differential expression based on tissue and developmental stage (Vassilev et al., 2001); however, 
all four TEADs require a transcriptional co-activator for efficient gene transcription (Vassilev et 
al., 2001). Drosophila express only one TEAD-family transcription factor Scalloped (Sd), which 
was originally shown to interact with the transcriptional coactivator, Vestigial (Vg) to regulate 
wing blade development (Halder et al., 1998; Paumard-Rigal et al., 1998; Simmonds et al., 
1998). However, Sd and Vg display very different expression patterns; Sd is expressed in a wide 
variety of tissues throughout embryonic and larval development, while Vg is restricted to the 
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wing imaginal disc (Campbell et al., 1992; Williams et al., 1991), suggesting that Vg may not 
mediate all of the transcriptional effects of Sd.  
YAP/TAZ and Yki have been shown to be highly efficient coactivators of the 
TEAD/TEF family. Yki, in association with Sd, promotes the expression of pro-growth and anti-
apoptotic genes, such as cyclin E and diap1 (Huang et al., 2005; Wu et al., 2008) (Fig. 4A). In 
addition, Yki can promote expression of the microRNA bantam, which suppresses the translation 
of the pro-apoptotic gene, hid (Peng et al., 2009). Interestingly, the upregulation of bantam 
appears to involve an interaction between Yki and the transcription factors Homothorax (Hth) 
and Teashirt (Tsh) (Peng et al., 2009), suggesting that, in mediating its pro-proliferative and anti-
apoptotic effects, Yki may be a more promiscuous coactivator than traditionally thought. YAP 
and TAZ can associate with all 4 mammalian TEADs to promote proliferation and oncogenic 
transformation (Chan et al., 2009; Vassilev et al., 2001; Zhao et al., 2009). Several gene targets 
of YAP/TAZ in association with TEAD have been identified. These include Connective Tissue 
Growth Factor (CTGF); the EGFR ligand, Amphiregulin (AREG); and the anti-apoptotic Bcl-2 
family protein, BIM (Vigneron et al., 2010; Yang et al., 2012; Zhang et al., 2009; Zhao et al., 
2008) (Fig. 4B). In addition, YAP has been shown to interact with p73 in response to DNA 
damage, where it promotes apoptosis, in direct contrast to its effect when associated with TEADs 
(Basu et al., 2003; Strano et al., 2005). This DNA damage-mediated activity of YAP is not 
regulated by the Hippo pathway, but is instead regulated by Akt (Basu et al., 2003). This 
suggests that YAP can be both pro-proliferative and pro-death, depending on context, and that its 
specificity is determined by its transcriptional binding partners and upstream regulatory signals.  
In response to Hippo pathway activation, active Lats/Wts phosphorylates YAP/TAZ/Yki 
on multiple serine residues, leading to its inactivation (Hao et al., 2008; Huang et al., 2005; Zhao 
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et al., 2007). Phosphorylated YAP/TAZ and Yki are sequestered in the cytosol via an association 
with 14-3-3 molecules (Ren et al., 2009; Zhao et al., 2007). Phosphorylated YAP and TAZ can 
also be ubiquitinated and targeted for proteasomal degradation (Liu et al., 2010; Zhao et al., 
2010b). In addition, YAP has been shown to associate with the tight junction protein, AMOT, or 
with α-catenin at adherens junctions, suggesting that the sequestration of YAP at cell junctions 
may be an additional means of preventing its transcriptional activity (Chan et al., 2011; 
Schlegelmilch et al., 2011; Zhao et al., 2011); however, it is unclear whether these methods of 
YAP regulation are dependent on the Hippo pathway and phosphorylation by Lats, or whether 
the sequestration of YAP/TAZ at junctions represents a Hippo-independent mechanism of 
inactivation (Chan et al., 2011; Murugan et al., 2011; Schlegelmilch et al., 2011; Zhao et al., 
2011). 
Upstream regulators of the Hippo pathway 
Many signals upstream of the core kinase complex are able to activate the Hippo pathway 
and promote growth arrest. In cultured cells, the Hippo pathway is activated in response to cell 
density, indicating that the Hippo pathway may regulate contact inhibition of proliferation, the 
process by which non-transformed cells growth arrest upon formation of a confluent sheet (Kim 
et al., 2011; Zhao et al., 2007). In vivo, the Hippo pathway is activated by organ size. In both 
flies and mammals, genetic deletion of Hippo pathway components or overexpression of 
Yki/YAP, results in organ overgrowth (Kango-Singh and Singh, 2009; Zhao et al., 2010a).  
At a molecular level, numerous upstream activators of the Hippo pathway have been 
identified. In Drosophila, the proto-cadherin Fat has been shown to activate the Hippo pathway 
by a Hpo-dependent and independent mechanism. In the Hpo-dependent mechanism, the 
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magnitude of gradients of the Fat ligands, Dachsous (Ds) and Four-jointed (Fj), regulate 
activation of Hpo and subsequent inactivation of Yki (Rogulja et al., 2008; Willecke et al., 
2008). Specifically, a juxtaposition of cells expressing different amounts of Ds and Fj causes 
inactivation of Fat, high Yki activity, and cell proliferation (Rogulja et al., 2008; Willecke et al., 
2008). Flattening of the Ds/Fj gradients of expression results in Fat activation and subsequent 
recruitment of the FERM-domain containing protein, Expanded (Ex) to the plasma membrane 
(Rogulja et al., 2008; Willecke et al., 2008).  
Ex is part of the Kibra-Expanded-Merlin (KEM) complex, which recruits Hpo and Sav to 
the plasma membrane and enhances Hpo activation (Genevet et al., 2010; Yu et al., 2010) (Fig. 
4A). In addition, Kibra can complex with Wts to affect its activation and the phosphorylation of 
Yki (Genevet et al., 2010). Similarly, mammalian Kibra can associate with Lats to promote its 
autophosphorylation and YAP inactivation, via an Mst-independent mechanism (Xiao et al., 
2011), although mammalian Kibra can also form a complex with NF2/Merlin (KM complex) 
(Fig. 4B), similar to the Drosophila KEM complex (Genevet et al., 2010). In addition, the 
mammalian Fat homolog, FatJ, and the mammalian Ex homolog, Willin/FRMD6, have been 
identified. While the role of FatJ in Hippo signaling has not been studied, FRMD6 has been 
shown to activate the Hippo pathway in mammalian cells. However, overexpression of FRMD6 
cannot functionally rescue loss of Ex in Drosophila, and FRMD6 does not interact with 
mammalian KIBRA or NF2/Merlin, most likely because FRMD6 does not contain the C-
terminal PPxY motifs that are present in Ex (Angus et al., 2011; Genevet et al., 2010). 
Interestingly, in Drosophila, Ex has been implicated in a phosphorylation-independent 
mechanism of Yki inactivation, where it binds to and sequesters Yki at the membrane via an 
association between its PPxY motifs and the WW domains of Yki (Oh et al., 2009). This is 
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similar mechanistically to YAP inhibition by the tight junction protein AMOT, suggesting that 
over time, the functions of Ex in the regulation of proliferation may have been split between 
different mammalian proteins (Angus et al., 2011; Zhao et al., 2011).  
Fat can also regulate Wts via a Hpo-independent mechanism, which involves the myosin 
Dachs (Cho et al., 2006). Fat activation by Ds and Fj results in stabilization of the Wts protein 
(Cho et al., 2006). In the absence of Fat activation, Dachs associates with Wts and promotes its 
degradation. Fat activation disrupts the association of Dachs with Wts, thereby preventing its 
degradation and enhancing the Wts-mediated inactivation of Yki (Cho et al., 2006). A 
mammalian equivalent to the Fat-Dachs signaling arm of Wts regulation has not been identified. 
Other upstream signals of Hippo pathway activation include cell polarity regulators, 
cytoskeletal components, and junctional molecules. The cell polarity proteins Crumbs (Crb), 
Lethal giant larvae (Lgl), and atypical PKC (aPKC) coordinately regulate Hippo pathway 
localization and activity. Disruption of cell polarity by loss of the neoplastic tumor suppressors 
Discs large (dlg), lgl, or scribble (scrib) (Scrib complex) leads to loss of tissue organization and 
overgrowth (Tepass, 2012). Disruption of the Scrib complex also leads to mislocalization of Crb 
into the basolateral membrane. This mislocalization of Crb leads to mislocalization of Ex and 
decreased Hpo activation, thus causing the tissue overgrowth (Grzeschik et al., 2010; Ling et al., 
2010; Parsons et al., 2010; Robinson et al., 2010). Tissues mutant for lgl, or overexpressing 
aPKC, on the other hand, demonstrate tissue overgrowth due to a mislocalization of Hpo away 
from the apical compartment (Parsons et al., 2010). The role of the mammalian polarity 
complexes on Hippo pathway activation has not been determined, although disruption of 
mammalian cell polarity regulators can affect cell proliferation and apoptosis in some contexts 
(Wodarz and Näthke, 2007). However, a direct recruitment of YAP/TAZ to the plasma 
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membrane via an interaction with Crumbs has been reported in response to cell density (Varelas 
et al., 2010), suggesting that cell polarity regulators can regulate the Hippo pathway both 
upstream and downstream of the Hippo core complex.  
Cytoskeletal components are likewise also important in mammalian Hippo activation 
(Schroeder and Halder, 2012). Increased cell tension, increased cell surface area, and F-actin 
content are all associated with Hippo pathway inactivation. Specifically, increasing cellular F-
actin content, by increasing the surface area to which cells can attach or by depleting cells of 
capping proteins, can increase cellular and tissue overgrowth via activation of YAP/TAZ/Yki 
(Dupont et al., 2011; Sansores-Garcia et al., 2011; Wada et al., 2011). In fact, these upstream 
signals, collectively referred to as mechanotransduction, are thought to represent a critical 
method of regulation of cell proliferation, and may be involved in cell contact inhibition of 
proliferation, since in cell culture, cell surface area and F-actin content both decrease with 
increased cell density (Schroeder and Halder, 2012). However, reports are mixed on whether 
mechanotransduction-mediated regulation of YAP/TAZ/Yki activity occurs via the canonical 
Hippo core kinase complex or via other, as-yet-unknown upstream regulators of YAP (Dupont et 
al., 2011; Sansores-Garcia et al., 2011; Wada et al., 2011). 
Finally, cell-cell junctions are also implicated in Hippo pathway regulation. Both 
adherens junction proteins, such as E-cadherin, β-catenin, and α-catenin in mammals, and the 
nectin Echinoid in Drosophila, as well as tight junction proteins such as AMOT, have been 
shown to recruit Hippo pathway members to points of cell-cell contact and to regulate their 
activity (Kim et al., 2011; Murugan et al., 2011; Schlegelmilch et al., 2011; Yue et al., 2012; 
Zhao et al., 2011). Specifically, depletion of E-cadherin or β-catenin, which disrupts adherens 
junctions, causes the translocation of YAP to the nucleus in a Hippo pathway-mediated manner 
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(Kim et al., 2011). In keratinocytes, α-catenin, in a Hippo-independent fashion, inactivates YAP 
by sequestering it in the cytoplasm (Schlegelmilch et al., 2011). Echinoid, the Drosophila nectin, 
binds Sav and recruits it, along with Hpo, to the plasma membrane, resulting in their activation 
(Yue et al., 2012). Finally, the tight junctional protein, AMOT, binds to both YAP and Lats, and 
may inhibit YAP activity either by enhancing Lats-mediated phosphorylation of YAP, or by 
binding to YAP directly and sequestering it in the cytosol (Murugan et al., 2011; Zhao et al., 
2011). Interestingly, adherens junctions help establish cell polarity and are required for the 
correct localization and formation of tight junctions (Das Thakur, 2010; Marrs et al., 1995; 
Nelson, 2003), so loss of adherens junctions could affect the Hippo pathway intrinsically as well 
as by impairing tight junctions and cell polarity. 
Subcellular localization in Hippo signaling 
 Numerous studies suggest that the Hippo pathway may be regulated by the subcellular 
localization of its components. Particularly, localization of the core kinase complex to the apical 
membrane appears to enhance its activation.  
Artificially targeting Mob1 or Mats to the plasma membrane increases the activation of 
Lats and Wts, respectively, and also increases downstream inactivation of YAP and Yki (Chow 
et al., 2009; Hergovich et al., 2005; Hergovich et al., 2006; Ho et al., 2009). Similarly, artificially 
targeting the Mst-regulator Rassf1A (described in more detail below) to the plasma membrane 
enhances the activation of Mst (Praskova et al., 2004). 
Several upstream activators of the Hippo pathway are associated with the apical 
membrane compartment and seem to function by recruiting different components of the core 
kinase complex. For example, the Drosophila nectin, Echinoid, recruits Sav to adherens 
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junctions and enhances Hpo activity (Yue et al., 2012). Similarly, one of the growth inhibitory 
mechanisms of the membrane-associated KEM complex is recruitment of Hpo to the apical 
membrane (Baumgartner et al., 2010; Yu et al., 2010). Likewise, the tight junction protein 
AMOT, is able to bind to Lats and YAP, and may function as a scaffold for Lats phosphorylation 
of YAP (Murugan et al., 2011). Conversely, disruption of the localization of Hpo at the apical 
membrane by aPKC overexpression or lgl deficiency inhibits Hippo pathway activity (Grzeschik 
et al., 2010; Parsons et al., 2010). 
Together these results indicate that the apical compartment constitutes an important 
regulator of Hippo signaling. However, it is unknown why this is so. It may be that the 
membrane simply provides a scaffold for complex assembly, or that required components for 
Hippo pathway activation are constitutively membrane localized.  
Modulators of Hippo signaling 
In addition to the mechanisms of Hippo activation described above, several modulators of 
Hippo signaling have been identified. These include the Rassf family proteins, the Ajuba LIM 
proteins, and the Zyxin LIM proteins.  
The Rassfs are a large family of Ras-associated, putative tumor suppressors that were 
identified as mediators of the cell cycle and apoptosis (van der Weyden and Adams, 2007). They 
contain a Ras-association (RA) domain and a Salvador-Rassf-Hippo (SARAH) domain and can 
interact with the SARAH domains of Hpo/Mst and Sav/WW45 (van der Weyden and Adams, 
2007). In flies, there is only one Rassf and it inhibits Hpo activation by competing with Sav for 
Hpo binding (Polesello et al., 2006) (Fig. 4A). When Hpo is bound to dRassf, it is less efficiently 
activated (Polesello et al., 2006). In mammals, there are six Rassf family members (van der 
15 
	  
Weyden and Adams, 2007). Of these, only 1A, 5, and 6 have been shown to regulate Mst1/2 
activity. Rassf6, like dRassf, inhibits Mst activity (Fig. 4B). It forms a tripartite complex with 
Mst and WW45, and inhibits Mst phosphorylation (Ikeda et al., 2009). However, Rassf6 also 
binds to WW45 and induces apoptosis in an Mst-independent manner (Ikeda et al., 2009). 
Rassf1A and Rassf5/Nore1 are different, in that they enhance Mst activation (Avruch et al., 
2006; Praskova et al., 2004) (Fig. 4B). While a mechanism for Rassf5 has not been found, 
Rassf1A has been shown to activate Mst by preventing its dephosphorylation by PP1 and PP2A 
(Guo et al., 2011). This is consistent with findings in Drosophila implicating a PP2A complex, 
the dSTRIPAK complex, as negative regulators of Hpo phosphorylation status and activity 
(Ribeiro et al., 2010).  
The Zyxin family of LIM proteins were recently shown to be negative regulators of the 
Hippo pathway in flies (Rauskolb et al., 2011). Loss of dZyx leads to small wing size and more 
Yki phosphorylation (Rauskolb et al., 2011). dZyx inhibits Wts via the Fat-mediated, Hpo-
independent arm, by binding to Dachs and Wts and enhancing Dachs-mediated Wts degradation 
(Rauskolb et al., 2011). This mechanism suggests a link between cytoskeletal cues (myosin) and 
cell proliferation, which is especially interesting in light of the proposed role of 
mechanotransduction in Hippo signaling (Rauskolb et al., 2011; Schroeder and Halder, 2012). 
However, a similar mechanism to the Fat-Dachs arm of Wts regulation has not been found in 
mammals, leaving unresolved the importance of Zyxin in mammalian Hippo pathway regulation.  
The Ajuba LIM proteins in Hippo pathway regulation 
Previous work from our lab and others has also identified the Ajuba LIM proteins as a 
novel negative regulator of the Hippo pathway in both Drosophila and mammals (Das Thakur et 
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al., 2010; Rauskolb et al., 2011). Depletion of the Drosophila Ajuba LIM family member, djub, 
causes a reduction in adult organ size, due to a decrease in cell number (Das Thakur et al., 2010) 
(Fig. 5B, F). Conversely, dJub overexpression causes organ overgrowth and an increase in Yki 
transcriptional targets, such as diap1 and cyclin E, and dJub genetically interacts with the Hippo 
pathway (Das Thakur et al., 2010) (Fig. 5C, G). Epistasis experiments place djub at the level of 
wts in the core kinase complex (Das Thakur et al., 2010) (Fig. 6B). Interestingly, the mammalian 
Ajuba LIM family member, LIMD1, which shares the greatest homology with dJub, can 
functionally rescue deficiency of djub in Drosophila tissues, suggesting that the Ajuba LIM 
proteins are evolutionarily conserved regulators of the Hippo pathway (Das Thakur et al., 2010). 
In addition to a genetic link between the Ajuba LIM proteins and the Hippo pathway, 
both dJub and the mammalian Ajuba LIM proteins (Ajuba, LIMD1, and WTIP) physically 
associate with Wts/Lats and Sav/WW45, in overexpression co-immunoprecipitation experiments 
(Das Thakur et al., 2010) (Fig. 6A). However, mammalian Zyxin does not associate with any of 
the Hippo pathway proteins, and dZyx only associates with Wts in the presence of Dachs (Das 
Thakur et al., 2010). Furthermore, in mammalian cultured cells, Ajuba and LIMD1 cause a 
decrease in the ability of the core kinase complex to phosphorylate, and thereby inhibit, YAP 
(Das Thakur et al., 2010). However, how the Ajuba LIM proteins regulate Hippo signaling, via 
Lats/Wts, is not known.  
Significance 
The regulation of organ and animal size during development is determined by both cell 
intrinsic and extrinsic signals (Stanger, 2008; Tumaneng et al., 2012). The Hippo pathway is a 
regulatory mechanism governing cell proliferation and apoptosis that may be a common 
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convergence point for a variety of upstream signals that modulate proliferation (Tumaneng et al., 
2012). However, how these upstream signals, encompassing information about the extracellular 
environment of the cell in question, are transmitted to the core kinase complex is not known. The 
Ajuba LIM proteins, which, as adaptor proteins that occupy multiple subcellular compartments, 
associate with junctional and cytoskeletal components, and act as co-regulators of transcription, 
could be important cellular messengers, linking environmental cues to intracellular signaling 
programs (Hou et al., 2008; Kanungo et al., 2000; Langer et al., 2008; Marie et al., 2003; Nola et 
al., 2011; Pratt et al., 2005). Our recent finding that the Ajuba LIM proteins physically and 
functionally intersect with the Hippo pathway suggested the possibility that these molecules 
could govern organ homeostasis by bridging upstream signals with the Hippo pathway (Das 
Thakur et al., 2010). Furthermore, the frequent disregulation of the Hippo pathway in human 
cancers suggests that the Hippo pathway, and molecules regulating it, may play a role in human 
disease.  
In this thesis, we address the question of how the Ajuba LIM proteins regulate Hippo 
signaling. First, we asked whether the physical association of the Ajuba LIM proteins with Lats 
or WW45 is important for its regulation, and if so, in what way. We found that, in fact, LIMD1 
enhanced the association of the core kinase complex, and that this enhanced complex formation 
was required for LIMD1-mediated Hippo pathway inhibition. Second, we asked whether the 
subcellular localization of either Ajuba or the Hippo pathway components was important for 
Ajuba LIM-mediated inhibition of the Hippo pathway. We observed that the Ajuba LIM proteins 
impaired Hippo pathway activity, and associated with Lats, in a density-dependent manner, such 
that at high density, when Ajuba and LIMD1 were recruited to adherens junctions, they were 
unable to impact the Hippo pathway. Consistent with this, we found that membrane-targeted 
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LIMD1 could not enhance complex formation or associate with Lats. We also found that 
targeting the core kinase complex to the membrane could enhance its activation and abolish its 
inhibition by LIMD1. Finally, we asked whether the Ajuba LIM proteins might have Lats-
independent effects on Hippo signaling. Consistent with this, we found that LIMD1 could impair 
Mst2 activation and associate with the Mst-regulators, Rassf6 and Rassf1A, suggesting that a 
secondary role of the Ajuba LIM proteins may be regulation of this upstream kinase.   
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Figure 1. Consensus sequence and topology of the LIM domain. The consensus sequence of 
the LIM domain, with the eight zinc-binding residues (1-8) marked, is shown in (A), while (B) 
demonstrates the topology of zinc coordination. (Adapted from: Kadrmas and Beckerle, 2004) 
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Figure 2. The Ajuba/Zyxin family of LIM proteins. (A) Schematic of the domain structure of 
the Ajuba/Zyxin LIM proteins; (B) Mammalian family members of the Ajuba LIM and Zyxin 
LIM families are shown (right), along with the Drosophila counterparts (left). 
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Figure 3. Disruption of the Hippo pathway results in organ overgrowth. (A) Wing imaginal 
disc overexpressing yki, as compared to control disc (inset); (B-B’) Scanning electron 
micrograph of a wild-type fly head (B) and a fly head overexpressing hpo (B’); (C) Livers from 
wild-type (left) and YAP overexpressing (right) mice, 4 weeks after YAP transgene induction; 
(D-D’) Tumor development in Mst1/2 null livers (D’) 13 months after cre induction, as 
compared to wild-type livers (D). (Adapted from: Dong et al., 2007; Huang et al., 2005; Lu et al., 
2010; Wu et al., 2003). 
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Figure 4. The Hippo pathway in Drosophila and mammals. Schematic of the Hippo signaling 
components in flies (A) and mammals (B). (Adapted from: Tumaneng et al., 2012) 
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Figure 5. dJub regulates organ size in Drosophila. (A-D) Effect of djub RNAi (B) or djub 
overexpression (C) on wing size, compared to wild-type (A). Wing outlines are shown in (D). 
(E-G) Effect of loss of djub (F) or djub overexpression (G) on the eye, compared to wild-type 
(E). (Adapted from: Das Thakur et al., 2010) 
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Figure 6. dJub interacts with the Hippo pathway at the level of the core kinase complex. (A) 
Co-immunoprecipitation of overexpressed Hippo pathway components with dJub from 
transfected S2 cell lysates. (B) Schematic of dJub-mediated regulation of the Hippo pathway. 
(Adapted from: Das Thakur et al., 2010) 
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Mechanism of Ajuba LIM-mediated inhibition of the Hippo pathway 
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Introduction 
 Proliferating metazoan cells, upon formation of a complete organ in vivo undergo growth 
arrest or cessation of proliferation, which is critical for the regulation of organ size in 
development, tissue regeneration and repair, and tumor suppression. Similarly, in a process 
known as contact inhibition of proliferation, non-transformed cultured epithelial cells also 
undergo growth arrest upon formation of a confluent sheet (McClatchey and Yap, 2012). In 
contrast, transformed or cancer cells frequently bypass these signals, giving rise to focal 
overgrowth (McClatchey and Yap, 2012). Research over the last decade has identified the Hippo 
tumor suppressor pathway as a critical modulator of cell proliferation and apoptosis in these 
contexts (Kim et al., 2011; McClatchey and Yap, 2012; Zhao et al., 2007).  
 At its core, the Hippo pathway is a kinase cascade. It was first identified in Drosophila as 
a signaling pathway that regulated organ size during development (Harvey et al., 2003; Huang et 
al., 2005; Justice et al., 1995; Kango-Singh et al., 2002; Pantalacci et al., 2003; Tapon et al., 
2002; Udan et al., 2003; Wu et al., 2003; Xu et al., 1995). Indeed, one of the early tumor 
suppressors, Wts or mammalian Lats, is a central protein kinase in the Hippo pathway. Most of 
the molecular components of the Hippo pathway are conserved between flies and mammals, and 
Hippo signaling has been implicated in both mammalian development and cancer development 
(Camargo et al., 2007; Dong et al., 2007; Lu et al., 2010; Song et al., 2010; St John et al., 1999; 
Zhou et al., 2009). In response to increasing cell density, cell-cell contacts form leading to 
changes in cytoskeletal architecture and activation of the Hippo kinase cascade that results in the 
phosphorylation and inactivation of the pro-proliferative and anti-apoptotic transcriptional co-
activators YAP and TAZ (Kim et al., 2011; Zhao et al., 2007). While the upstream signals 
leading to activation of the Hippo pathway appear to be diverse, the core components of the 
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canonical kinase cascade are conserved. The Ste-20 kinases, Mst1 and Mst2, along with the WW 
domain-containing scaffold, WW45, bind to and phosphorylate Mob1, which then enhances the 
phosphorylation and activation of its binding partners, the Ndr-kinases Lats1 and Lats2, by Mst 
(Chan et al., 2005; Hergovich et al., 2006; Luo et al., 2009; Praskova et al., 2008). Lats1/2 in 
turn bind to and phosphorylate YAP and TAZ on multiple serine residues, some of which lead to 
the sequestration of YAP/TAZ in the cytosol, and others of which lead to the degradation of 
YAP/TAZ by the proteasome (Liu et al., 2010; Zhao et al., 2010; Zhao et al., 2007). In the 
absence of Lats-mediated phosphorylation (i.e. Hippo pathway off), YAP and TAZ are 
predominantly nuclear where they bind to the TEAD family of transcription factors and enhance 
the transcription of pro-proliferative and anti-apoptotic genes (Chan et al., 2009; Ota and Sasaki, 
2008; Vassilev et al., 2001; Yang et al., 2012; Zhang et al., 2009; Zhao et al., 2008).  
 When cells in culture are sparse, the Hippo pathway is off and cells proliferate; however, 
upon formation of a dense confluent sheet of cells the Hippo pathway is activated and cell 
proliferation ceases. In vivo, the reestablishment of proliferation via inactivation of the Hippo 
pathway may be critical during wound healing processes and in the contexts of tissue 
regeneration (e.g. intestinal regeneration after chemotherapy, liver regeneration post-resection). 
Furthermore, constitutive activation or overexpression of YAP has been associated with poor 
prognosis in a number of human cancers (Wang et al., 2010; Xu et al., 2009). Understanding 
how the Hippo pathway is turned off or kept off so as to allow cell proliferation to resume or 
continue, respectively, could provide crucial insight into these processes. In mammals, while 
many molecular components that stimulate Hippo activity (e.g. Nf2/Merlin, E-cadherin and its 
associated catenins, polarity regulators such as Crumbs) have been identified, very little is 
known about the mechanisms keeping the Hippo pathway in check (Hamaratoglu et al., 2006; 
	  
	  
44 
Kim et al., 2011; Varelas et al., 2010; Zhang et al., 2010). The Ras-associated protein, Rassf6 is 
one of the few identified negative regulators of the Hippo pathway in mammals and has been 
shown to inhibit Mst2 activity by binding with WW45 and Mst2 in a tripartite complex (Ikeda et 
al., 2009). One other such negative regulator of the Hippo pathway is the Ajuba family of LIM 
domain-containing proteins, of which there are three mammalian family members, Ajuba, 
LIMD1 and WTIP, and one Drosophila ortholog, djub (Das Thakur et al., 2010; Rauskolb et al., 
2011). djub is an essential gene for Drosophila embryo development, for reasons that are not 
fully understood (Das Thakur et al., 2010). Depletion of djub in developing organs causes a 
decrease in organ size via a genetic interaction with the Hippo pathway (Das Thakur et al., 
2010). Genetic epistasis experiments indicate that the Ajuba LIM proteins inhibit Hippo pathway 
signaling upstream of YAP, at the level of the core kinase complex (Das Thakur et al., 2010). 
Consistent with this, biochemical experiments using overexpressed proteins in HEK293T cells 
show that the Ajuba LIM proteins physically interact with the core kinase complex components, 
Lats1/2 and WW45, and also inhibit YAP phosphorylation (Fig. 1A, B) (Das Thakur et al., 
2010).  
While experiments in Drosophila and mammalian cells confirm that Ajuba LIM-
mediated regulation of the Hippo pathway is conserved across species, it is not known exactly 
how the Ajuba LIM proteins inhibit Hippo pathway signaling, other than that it occurs at the 
level of the core complex. One can envision several possible mechanisms. First, the Ajuba LIM 
proteins could prevent the activation of Lats2 by the upstream kinase Mst2, or by preventing 
Lats2 autophosphorylation. Alternatively, the Ajuba LIM proteins could affect the association of 
various core complex components with each other, thereby impairing Hippo pathway activity. To 
address these different possibilities, we utilized several experimental systems, including contact 
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inhibition of proliferation, overexpression in mammalian cell lines, and organ development in 
Drosophila. We found that the Ajuba LIM proteins physically interacted with the core kinase 
complex components in a density dependent manner, and by doing so, sequestered active Lats in 
a complex, preventing the Lats-mediated phosphorylation and inhibition of YAP. Furthermore, 
we demonstrated that the Ajuba LIM proteins were critical for preventing inappropriate Hippo 
pathway activation in proliferative states. 
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Results 
The Ajuba LIM proteins prevent Hippo pathway activation and YAP inhibition in 
proliferating cell cultures  
In non-transformed cultured cells, contact inhibition of proliferation provides a useful 
experimental setting in which to explore regulation of the Hippo pathway. When cells are at low 
density such that few are in contact with one another, the Hippo pathway is off, YAP is active, 
and cell proliferation is maximal. However, when cells are grown to high density or the tissue 
culture plate is fully confluent, cell-cell contact is maximized, causing activation of the Hippo 
pathway and subsequent growth arrest. Thus, we used the normal breast epithelial cell line, 
MCF10A, to determine how Ajuba LIM proteins affect Hippo pathway activity. In confluent, 
high density cultures (i.e. contact inhibited) the Hippo pathway was activated, as evidenced by 
increased phosphorylation of YAP at S127 (Zhao et al., 2007) (Fig. 2A) and decreased YAP 
transcriptional activity as measured by a TEAD luciferase reporter (Ota and Sasaki, 2008) (Fig. 
2C). To determine the role of the Ajuba LIM proteins in Hippo-mediated contact inhibition, two 
of the three mammalian Ajuba LIM proteins, LIMD1 and Ajuba, were RNAi-depleted in 
MCF10A cells, either individually or together, and cells then plated at low or high density. 
Depletion of endogenous Ajuba or LIMD1 alone in epithelial MCF10A cells resulted in a small, 
statistically insignificant increase in Hippo pathway activity only in cells at low density (Fig. 2A, 
C).  But when both Ajuba and LIMD1 were RNAi-depleted, Hippo pathway activity was 
significantly increased in cells at low density, indeed approaching the level of Hippo activity 
present in contact inhibited parental cells (i.e. high density cultures). In low density cultures 
depleted of Ajuba and LIMD1, there was a 2-fold increase in YAP S127 phosphorylation (Fig. 
2A) and a 2-fold decrease in YAP transcriptional activity (Fig. 2C). However, depletion of Ajuba 
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and LIMD1 in high density cultures had no effect upon Hippo pathway activation. We were 
unable to RNAi-deplete all three Ajuba LIM proteins as doing so resulted in apoptosis, in 
agreement with results seen in Drosophila where the single Ajuba LIM gene, djub, was found to 
be an essential gene for embryonic development. We further confirmed these results in a second 
contact-inhibited epithelial cell line, MDCK. YAP phosphorylation was increased at high 
density, though these cells also exhibited a decrease in total YAP levels, consistent with reports 
that Lats-mediated phosphorylation of YAP on S381 leads to its ubiquitination and proteasomal 
degradation (Zhao et al., 2010). In these cells, RNAi-mediated depletion of Ajuba, but not 
LIMD1, caused an increase in YAP phosphorylation and a decrease in YAP protein levels, but, 
as in MCF10A cells, only in low-density cultures (Fig. 2B).  
All three Ajuba LIM proteins associate with the core Hippo pathway components Lats1/2 
and WW45 when co-transfected into HEK293T cells (Das Thakur et al., 2010) (Fig. 1A). To 
determine whether endogenous Ajuba LIM proteins associate with endogenous WW45 or 
Lats1/2 and if this association correlates with their inhibitory effect on the Hippo pathway, we 
immunoprecipitated LIMD1 or Ajuba from MCF10A cells cultured at low and high density and 
performed Western blots for the presence of associated WW45 or Lats1/2. Consistent with the 
co-IP results from HEK293T cells, endogenous Lats1/2 co-immunoprecipitated with endogenous 
LIMD1 and Ajuba at both low and high density (Fig. 3A); however, unlike in the overexpression 
setting, endogenous WW45 was not detected in complex with either Ajuba or LIMD1, although 
this may reflect a limitation in the sensitivity of the antibody. If the Lats-LIM protein association 
in cells was required for the Ajuba LIM proteins to inhibit the Hippo pathway, then we would 
predict that the interactions would occur preferentially in cells at low density, when depletion of 
Ajuba LIM proteins affected Hippo signaling, versus at high density, when depletion of Ajuba 
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LIM proteins had no effect. Importantly, the association of Lats1/2 with Ajuba and LIMD1 was 
by far greatest in cells plated at low density (Fig. 3A) when the Hippo pathway is minimally 
active and depletion of the Ajuba LIM proteins had the greatest effect on Hippo signaling. 
Similarly, when we immunoprecipitated Ajuba from MDCK cells at low and high density, we 
found Lats1, but not WW45, in the bound products, and once again more so at low density that at 
high density (Fig. 3B). Interestingly, and consistent with our observation that depletion of 
LIMD1 in MDCK cells had no effect on YAP phosphorylation, neither Lats1 nor WW45 co-
immunoprecipitated with LIMD1 at either low or high density (Fig. 3B). 
These data indicated that Ajuba and LIMD1 function to limit Hippo pathway activity in 
proliferating cells at low density, when Hippo pathway activity must be low to allow for cells to 
proliferate and survive. However, Ajuba LIM proteins did not affect Hippo pathway activation at 
high density, in response to cell-cell contact. The observation that Ajuba and LIMD1 exhibited 
different relative importance in MCF10A cells versus MDCK cells suggested that regulation of 
the Hippo pathway by the Ajuba LIM proteins could vary by tissue and cell type. Furthermore, 
these data indicated that the physical association between the Ajuba LIM proteins and Lats1/2 
may be important for their density-dependent inhibition of Hippo signaling. 
LIMD1 sequesters active Lats2 in the core kinase complex to inhibit Hippo signaling 
To determine how the Ajuba LIM proteins inhibit the Hippo pathway, we first 
reconstituted activation of Lats2 by the Hippo pathway in HEK293T cells and then asked 
whether LIMD1 affected Lats2 activation. HEK293T cells are fully transformed, human 
embryonic kidney cells and as such do not undergo growth cessation in response to increasing 
cell-cell contact or density. We overexpressed Lats2 in combination with the other upstream 
	  
	  
49 
components of the core Hippo pathway kinase complex: Mst2, WW45, and Mob1A, in the 
presence or absence of overexpressed LIMD1, and measured Lats2 activation by Mst2 by 
Western blotting with a Lats2 phospho-specific T1041 antibody (Visser and Yang, 2010). We 
also assessed Lats2 auto-phosphorylation, which is required for Lats2 kinase activity, by Western 
blotting with a Lats2 phospho-specific S872 antibody (Visser and Yang, 2010). Expression of 
Mst2 and Mob1A was sufficient to induce maximal activation of Lats2 (Fig. 4A, lane 7). The 
addition of WW45 did not further enhance Lats2 activation in these cells (Fig. 4A, lane 9). 
Expression of LIMD1, in all conditions, inhibited Lats2 activation by Mst2 (Fig. 4A), though it 
only inhibited Lats2 auto-phosphorylation when Mob1A was also overexpressed (Fig. 4A, lane 
7, 9). Due to the correlation between the phosphorylation status of Lats2 on T1041 and S872 in 
the context where the full complex is overexpressed (Fig. 4A, lane 8, 9), in all subsequent 
experiments, we assessed Lats2 phosphorylation on T1041 as a measure of activated Lats2. 
Given that the addition of Mob1A to the complex appeared to be sufficient to induce maximal 
Lats2 activation, we asked whether Mob1A alone could stimulate Lats2 activation in the absence 
of Mst2 (Fig. 4B). Once again, Mst2 and Mob1A co-expression resulted in robust Lats2 
activation that was inhibited by addition of LIMD1 (Fig. 4B, lane 7,8). However, the 
overexpression of Mob1A alone was insufficient to activate Lats2, and the addition of LIMD1 
had no effect (Fig. 4B, lane 5,6).  
The interaction of Lats1/2 with Mob1 is important for Lats1/2 activation (Hergovich et 
al., 2006). Similarly, the association of WW45 with Mst2 promotes Hippo pathway activation 
and one known mechanism of inhibition of the Hippo pathway is via disruption of this 
association by Rassf family proteins (Ikeda et al., 2009; Lee et al., 2008; Polesello et al., 2006). 
Furthermore, all four components, Mst2, Lats1/2, WW45, and Mob1A, form a physical complex 
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in cells and formation of this complex is thought to be important for activation of the pathway as 
a whole (Sudol and Harvey, 2010). Therefore, we asked whether LIMD1 inhibited Lats2 
activation by affecting the association of the different Hippo complex components. LIMD1 
associates with Lats2 but transfection of increasing amounts of LIMD1 along with Lats2 and 
Mob1A did not affect the association of Mob1A with Lats2 (Fig. 5A). LIMD1 also associates 
with WW45, but increasing amounts of LIMD1 did not disrupt or enhance the association of 
Mst2 with immunoprecipitated WW45 (Fig. 5B) or WW45 with immunoprecipitated Mst2 (Fig. 
5C). We then asked whether LIMD1 affected the association of the complex as a whole. To do 
so we overexpressed all four components of the core kinase complex, in the absence of LIMD1 
or with increasing amounts of LIMD1, immunoprecipitated Mst2, and performed Western blots 
for Hippo pathway components in the bound products. In the absence of LIMD1, WW45, Lats2 
and Mob1A were found to co-immunoprecipitate with Mst2 (Fig. 6A, lane 6). In the presence of 
LIMD1, the association of Lats2 and Mob1A, but not WW45, with Mst2 was enhanced (Fig. 6A, 
lane 7, 8, quantified in 6B and 6D). LIMD1 was also present in the Mst2-immunoprecipitated 
Hippo core kinase complex (Fig. 6A). Importantly, while the amount of active Lats2 in the whole 
cell lysate was decreased in the presence of LIMD1 (Fig. 6A, lane 3, 4, quantified in 6E) as 
expected, the amount of active Lats2 that co-immunoprecipitated with Mst2 was increased in the 
presence of LIMD1 (Fig. 6A, lane 7, 8, quantified in 6C).  These results suggested the possibility 
that the Ajuba LIM proteins limited Hippo pathway activity by sequestering active Lats2 in a 
LIMD1-containing core Hippo kinase complex. 
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LIM1 and LIM2 domains mediate the physical and functional interaction of LIMD1 with 
the core kinase complex 
The C-terminal region of the Ajuba LIM proteins contains three tandem LIM domains. It 
is this region that directs their association with Lats2 (Abe et al., 2006). Since any one individual 
LIM domain or combination of LIM domains can direct specific protein-protein interactions, we 
asked which LIM domain(s) of LIMD1 was required for its association with Lats2 individually 
and with the complete core Hippo kinase complex. In addition, we determined whether this 
mapping correlated with the ability of LIMD1 to limit Hippo activity in vivo during Drosophila 
wing development. Using a panel of LIMD1 mutants that had various LIM domain(s) deleted 
(Fig. 7A) both LIM1 and LIM2 domains were found to be required for the efficient association 
of LIMD1 with Lats2 in cells (Fig. 7B). Deletion of either domain alone was not sufficient to 
disrupt the Lats2-LIMD1 association, however, removal of both LIM1 and LIM2 domains 
abrogated the interaction between LIMD1 and Lats2 (Fig. 7B). In agreement with the mapping 
results, the LIMD1 mutant lacking both LIM1 and LIM2 domains did not inhibit S127 
phosphorylation of YAP, while the mutant lacking the LIM3 domain was as efficient as wild-
type LIMD1 (Fig. 7C, D).   
Next, we asked which LIM domains were required for the association of LIMD1 with the 
full core Hippo kinase complex and sequestration of active Lats2. Again the association of 
LIMD1 with the Mst2-immunoprecipitated core complex required both LIM1 and LIM2 
domains, though in this case, loss of either domain individually significantly decreased the 
amount of LIMD1 mutant protein associated with the complex (Fig. 8A, lanes 15-17). 
Interestingly, removal of the LIM3 domain increased the amount of LIMD1, as well as Lats2 and 
Mob1A, that associated with the Mst2 immunoprecipitated complex (Fig. 8A, lane 18), 
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suggesting that this domain may physically interfere with access to either the LIM1 or LIM2 
domains. In agreement with the mapping results for the physical association between the LIMD1 
mutants and the core Hippo kinase complex, removal of either the LIM1 or LIM2 domains 
reduced the amount of active Lats2 present in the Mst2 immunoprecipitated complex (Fig. 8A, 
quantified in 8B). Again, removal of the LIM3 domain dramatically increased the amount of 
active Lats2 in the Mst2 immunoprecipitate (Fig. 8A, lane 18; quantified in 8B). 
Finally, we asked whether the interaction between LIMD1 and the Hippo core kinase 
complex and its sequestration of active Lats2 was required for LIMD1 to limit Hippo activity 
during Drosophila wing development. To do so we made transgenic flies expressing various 
human LIMD1 mutants and determined which ones were able to rescue the dJub RNAi small 
wing phenotype. Depletion of djub results in a decrease in adult wing size due to its effects upon 
cell proliferation regulated by the Hippo pathway (Das Thakur et al., 2010). Importantly, this 
phenotype can be rescued by overexpression of human LIMD1, the closest mammalian Ajuba 
LIM relative to djub, in djub RNAi wings (Das Thakur et al., 2010) (Fig. 9C).  
Only hLIMD1 mutants that strongly associated with the core Hippo kinase complex and 
sequestered active Lats2 with the complex, namely full-length LIMD1 or the mutant lacking the 
LIM3 domain were able to rescue the small wing phenotype (Fig. 9C, I). Transgenic hLIMD1 
mutants lacking either LIM1, LIM2, or both domains did not rescue the wing phenotype (Fig. 
9D-H). Control experiments confirmed expression of the various transgenes at the cell surface of 
wing imaginal disc epithelial cells (Fig. 10). These experiments showed a direct correlation of 
the in vivo functional inhibition of Hippo activity with the ability of human LIMD1 to associate 
with and sequester active Lats2 into the core Hippo kinase complex. 
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LIMD1 inhibits the association of Lats2 with YAP 
 The experiments in Drosophila and HEK293T cells using the LIMD1 domain mutants 
demonstrated that the enhanced association of active Lats2 with the core kinase complex, 
mediated by LIMD1, was important for the negative regulation of Hippo pathway signaling. 
However, it was unclear why this enhanced complex formation inhibited YAP activity. One 
possibility was that LIMD1, when associated with the complex, prevented Lats2 from interacting 
with YAP. To test this possibility, we overexpressed the core kinase complex in HEK293T cells 
along with YAP, in the presence or absence of LIMD1, immunoprecipitated Lats2, and blotted 
for YAP in the bound products. We found that while YAP co-immunoprecipitated with Lats2 
both in the presence and absence of LIMD1, there was ~50% less YAP associated with Lats2 in 
the presence of LIMD1 (Fig. 11). Conversely, the presence of LIMD1 also increased the amount 
of Mst2 and WW45 associated with Lats2 by ~2-fold (Fig. 11), consistent with increased 
association of Lats2 with Mst2 IPs.  
  
	  
	  
54 
Discussion 
 Several studies have outlined a mechanism for Hippo complex activation. Specifically, it 
has been shown that Mob1 phosphorylation by Mst2 is critical for the recruitment of Lats to the 
complex and for its subsequent phosphorylation by Mst (Bao et al., 2009; Praskova et al., 2008). 
Interestingly, our results suggest that the Ajuba LIM proteins inhibit Hippo pathway signaling by 
increasing the association of both Mob1 and Lats2 with the core kinase complex. Why enhanced 
complex association would inhibit Hippo signaling is, however, unclear. One possibility is that 
this complex, when associated with the Ajuba LIM proteins, has less affinity for YAP, thereby 
preventing YAP phosphorylation and inactivation. Consistent with this, we found that in the 
presence of LIMD1, YAP was less efficiently immunoprecipitated by Lats2. However, these 
results do not exclude other possible mechanisms of Hippo pathway inhibition by the Ajuba LIM 
proteins. For example, while YAP phosphorylation by Lats has been associated with YAP 
translocation from the nucleus to the cytosol, it is still unclear in which subcellular compartment 
Lats phosphorylates YAP. Both Lats and YAP have been reported to be in the nucleus, the 
cytoplasm, and the plasma membrane, depending on context and cell type (Hergovich et al., 
2006; Lee et al., 2008; Murugan et al., 2011; Varelas et al., 2010; Zhang et al., 2012; Zhao et al., 
2011). Therefore, it is possible that the Ajuba LIM proteins prevent Hippo pathway signaling by 
sequestering the core complex in a subcellular compartment separate from YAP. Further 
experiments to address where the Lats-YAP interaction occurs would help address these 
possibilities and could provide more insight into the role of the Ajuba LIM proteins in Hippo 
signaling. 
 Our experiments in contact inhibited epithelial cells suggest a density-dependent role for 
the Ajuba LIM proteins in regulating Hippo pathway signaling. Specifically, the Ajuba LIM 
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proteins only prevent YAP inactivation in low density, proliferating cells, while having no effect 
in high density cells. Thus, the Ajuba LIM proteins do not prevent activation of the Hippo 
pathway, but keep it off in settings where proliferation is required. How a cell “knows” when it 
is no longer at low density, and thus should release the Hippo pathway from Ajuba LIM-
mediated inhibition is unknown. It has previously been shown that the Ajuba LIM proteins are 
recruited to adherens junctions via an association with α-catenin, and that this recruitment to 
points of cell-cell contact is important for junctional maturation and cell-cell adhesion (Marie et 
al., 2003; Nola et al., 2011). Interestingly, several recent papers have shown that disruption of 
adherens junction, by low calcium or depletion of E-cadherin or β-catenin, in epithelial cells 
leads to a loss of density sensing and upregulation of YAP activity in high density cells, although 
the mechanism has not been shown (Kim et al., 2011; Varelas et al., 2010). Given that junctions 
form and mature as cells become more confluent, one possibility is that recruitment of Ajuba 
LIM proteins to the plasma membrane at high density releases their inhibition of the Hippo 
pathway, leading to YAP phosphorylation and inactivation (Fig. 12); conversely, disruption of 
adherens junctions at high density, which causes cytoplasmic accumulation of Ajuba and 
LIMD1, may restore Ajuba LIM-mediated inhibition of the Hippo pathway and lead to 
upregulation of YAP activity. This mechanism would place the Ajuba LIM proteins as critical 
mediators of the process of cell density sensing and subsequent growth arrest and would suggest 
that the subcellular localization of the Ajuba LIM proteins plays a key role in the regulation of 
their activity.  
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Materials and Methods 
Cell culture and transfections 
MCF10A cells were cultured in 1:1 DMEM/F12 (Gibco) supplemented with 5% heat-
inactivated horse serum (Gibco), 100ng/mL Cholera toxin, 10µg/mL insulin, 20ng/mL EGF, 
500ng/mL hydrocortisone, 200µM L-glutamine (Cellgro), and penicillin/streptomycin (Gibco). 
MDCK cells were cultured in 1x MEM Alpha (Gibco) supplemented with 10% heat-inactivated 
FBS (Sigma), 200µM L-glutamine, and penicillin/streptomycin. HEK293T cells were cultured in 
DMEM (Gibco) supplemented with 10% heat-inactivated FBS, 200µM L-glutamine, and 
penicillin/streptomycin.  
 Lipofectamine RNAiMAX (Invitrogen) was used to transfect MCF10A and MDCK cells 
with siRNA directed against Ajuba and LIMD1, according to manufacturer’s instructions. For 
density experiments, equal numbers of cells were transfected and plated on dishes of different 
sizes to as to have cells at low and high densities. All experiments were conducted forty-eight 
hours post-transfection.  
 TransIT-LT1 reagent (Mirus) was used to transfect HEK293T cells with indicated 
plasmids, according to manufacturer’s instructions. 
TEAD-luciferase reporter experiments 
 For TEAD-luciferase experiments, the TEAD-luciferase lentiviral vector was transfected, 
along with packaging plasmids, into HEK293T cells. Media was changed twenty-four hours 
post-transfection. Viral supernatant was collected twenty-four hours after the media change, 
filtered through a 0.45µm filter, and used to infect plated MCF10A cells. Infections were done in 
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the presence of 10µg/mL protamine sulfate. Forty-eight hours post-infection, MCF10A cells 
were subject to selection with 10µg/mL blasticidin for four days. Stable clones were pooled and 
maintained in 2.5µg/mL blasticidin. 
 For each experiment, MCF10A cells stably expressing the TEAD-luciferase reporter 
were transfected as indicated and plated on black-walled 24-well plates at low and high density. 
48 hours later, D-luciferin was added and luciferase activity was measured. Cell number was 
determined by MTT assay, and luciferase flux normalized to cell number.  
Immunoprecipitation, Western blotting and antibodies used 
 Cells were lysed in RIPA buffer (50mM Tris pH 8.0, 150mM NaCl, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS) supplemented with 200nM PMSF, 2µg/mL 
Aprotinin/Leupeptin, 2µM Pepstatin A, 1mM Na3VO4, and 2mM NaF. Lysates were cleared by 
centrifugation at 12,000 rpm for 10 minutes and concentration determined by Bradford assay 
(Bio-Rad). Equal amounts of protein were boiled in SDS sample buffer, resolved by 8% or 10% 
SDS-PAGE and transferred to PVDF membranes (Millipore) in transfer buffer (25mM Tris, 
192mM glycine, 5% methanol). Membranes were blocked with TBST (25mM Tris pH 7.4, 
150mM NaCl, 2mM KCl, 0.5% Tween-20) containing 5% skim milk powder or BSA and probed 
overnight with indicated primary antibodies. Bound antibodies were detected by HRP-
conjugated secondary antibodies and developed with SuperSignal West Pico or West Femto ECL 
(Pierce). Images were collected on a Bio-Rad ChemiDoc XRS+ and subject to quantification 
using ImageJ software. The following antibodies were used: rabbit α-YAP (Cell Signaling 
#4912, 1:1000), rabbit α-phospho-YAP (Ser127) (Cell Signaling #4911, 1:1000), rabbit α-Lats1 
(Cell Signaling #3477, 1:500), rabbit α-Ajuba (Cell Signaling #4897, 1:1000), rabbit α-LIMD1 
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(Ref) (1:1000), mouse α-Flag M2 (Sigma F3165, 1:1000), mouse α-HA (Sigma H3663, 1:1000), 
mouse α-Myc 9E10 (Millipore 05-419, 1:1000). Rabbit α-Lats2 (1:1000), rabbit α-phospho-
Lats2 T1041 (1:250), and rabbit α-phospho-Lats2 S872 (1:250) were from H. Nojima (Osaka 
University, Japan); rabbit α-WW45 (1:1000) was from G. Pfeifer (Beckman Research Institute of 
the City of Hope) (Guo et al., 2007). 
 For immunoprecipitations, cells were lysed in immunoprecipitation (IP) buffer (10mM 
HEPES pH 7.4, 150mM NaCl, 10% glycerol, 1% NP-40 or CHAPS) supplemented with 200nM 
PMSF, 2µg/mL Aprotinin/Leupeptin, 2µM Pepstatin A, 1mM Na3VO4, and 2mM NaF. Lysates 
were cleared by centrifugation at 12,000 rpm for 10 minutes and concentrations determined by 
Bradford assay (Bio-Rad). Equal amounts of protein were collected, of which 10% was boiled in 
SDS sample buffer and saved as “Input” and the remainder incubated with indicated antibodies, 
with rocking, overnight at 4 degrees. The next day, Protein G-conjugated sepharose beads 
(Sigma) were added to each reaction at 5µL bed volume/200µg lysate and rocked for 1 hour at 4 
degrees. Immunoprecipitates were washed 3 times with 1.5mL IP buffer, followed by 
centrifugation at 100xg for 1 minute. The following antibodies were used: rabbit α-Ajuba (Cell 
Signaling #4897), rabbit α-LIMD1 (Feng et al., 2007) (PVDF-purified), mouse α-HA (Sigma 
H3663). Rabbit α-Myc was provided by A. Shaw (Washington University in St. Louis). 
Immunostaining 
 Cells plated on glass coverslips were fixed in 4% paraformaldehyde (PFA) dissolved in 
PBS and permeabilized with 0.2% Triton X-100 in PBS. All cells were blocked in 5% normal 
goat serum (NGS) for 1 hour at room temperature and incubated with indicated primary 
antibody, diluted in PBS + 1% NGS, overnight at 4 degrees. Coverslips were washed 3 times 
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with PBS, then incubated with secondary antibody diluted in PBS + 1% NGS for 1 hour at room 
temperature. Cells were mounted in Vectashield mounting medium containing DAPI (Vector 
Labs). Images were collected on a LSM 510 Zeiss confocal microscope using a 40x oil objective. 
ImageJ was used to process the images. The following antibodies were used: rabbit α-YAP (Cell 
Signaling #4912, 1:500), mouse α-E-cadherin (BD Biosciences 610182, 1:500), Alexa Fluor 488 
and 568 secondary antibodies (Invitrogen, 1:250). 
 Wing imaginal discs were dissected in PBS, following which the tissue was fixed in 4% 
paraformaldehyde dissolved in PBS. After fixation, tissues were permeabilized with PBX (0.1% 
Triton X-100 in PBS), washed in PAXD buffer (1% BSA, 0.3% Triton X-100, 0.3% sodium 
deoxycholate in PBS), and incubated at 4 degrees overnight with indicated primary antibodies 
diluted in PAXDG buffer (5% NGS in PAXD). Tissues were then washed 3 times in PBX , and 
incubated with secondary antibody diluted in PAXDG for 4 hours. Tissues were rinsed with PBS 
and transferred to slides for mounting in Vectashield mounting medium containing DAPI 
(Vector Labs). Images were collected on a LSM 510 Zeiss confocal microscope using a 63x oil 
objective. ImageJ was used to process the images. The following antibodies were used: mouse α-
HA (Sigma H3663, 1:100), rat α-DE-cadherin (IC, 1:20), Alexa Fluor 488 and Cy5 secondary 
antibodies (Invitrogen, 1:100). 
Transgenic fly lines 
 UAS-HA-hLIMD1 flies were described previously. For the LIMD1 domain mutants, 
cDNA was cloned into pUAST-HA and the resulting vectors were used to generate transgenes 
via standard P element-mediated transformation (Rainbow Transgenics, Inc). 
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GAL4/UAS analysis 
Gene over-expression and RNAi-rescue assays were carried out using the GAL4/UAS system. 
GAL4 driver line used: 1096-gal4. UAS lines used: UAS-djubRNAi (22.5), UAS-dcr, UAS-HA-
hLIMD1 and hLIMD1 domain mutants.  
 
Fly Crosses and Staging of Larvae 
 
All crosses took place at 25°C. Wandering third instar larvae were used for third instar 
imaginal disc dissections. 
Mounting of Adult Wings and Statistics 
 
Adult flies were stored in 80% ethanol until ready for dissections. Only female flies were 
used for analyses. Wings were removed in 75% glycerol (in PBS) for mounting. Coverslips were 
sealed with nail polish. Total wing area was measured and the average and standard deviation 
plotted using ImageJ and Microsoft Excel. Student’s T test was used to calculate statistical 
significance of the area of the wing region between various genotypes. 
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Figure 1. LIMD1 physically and functionally interacts with the Hippo pathway. (A) 
HEK293T cells were transfected with Flag-LIMD1, along with indicated components of the 
Hippo pathway. Lysates were immunoprecipitated with a LIMD1 antibody and Western blotted 
for Hippo pathway components in the bound products. (B) HEK293T cells were transfected with 
Flag-YAP with or without Flag-LIMD1. Cell lysates were subject to Western blotting and 
probed with indicated antibodies. The amount of pYAP S127 relative to total YAP was 
quantified and is shown below the pS127 YAP panel.  
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Figure 2. Depletion of Ajuba and LIMD1 leads to Hippo pathway activation in low density 
cell cultures. MCF10A cells (A) or MDCK cells (B) were transfected with a non-targeting 
negative control (Ctrl) siRNA, LIMD1 siRNA, Ajuba siRNA, or both LIMD1 and Ajuba siRNAs 
and plated at low density (LD) or high density (HD). Cell lysates were subjected to Western 
blotting to determine the amount of YAP phosphorylation at S127. pS127 YAP was quantified 
relative to total YAP for each sample. The relative level of phosphorylated YAP is indicated 
below the pS127 YAP panel. For the MDCK cells, the relative amount of total YAP is indicated 
below the YAP panel. Arrow designates a non-specific band. (C) MCF10A cells infected with a 
lentivirus expressing the GTIIC-Luciferase TEAD reporter (Ota and Sasaki, 2008) were 
transfected with indicated siRNAs at low and high density. Relative luciferase activity was an 
indicator of YAP transcriptional activity. Values are means +/- s.d. from three independent 
experiments. *P<0.05.  
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Figure 3. Endogenous Ajuba and LIMD1 associate with Lats1/2, but not WW45, in low 
density cells. LIMD1 or Ajuba was immunoprecipitated from MCF10A cells (A) or MDCK cells 
(B) at low or high density and Western blotted for Lats1/2 and WW45 in the bound products. 
Western blots of the input controls (10%) are shown in the left panels.   
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Figure 4. LIMD1 inhibits Lats2 activation by the core kinase complex. HEK293T cells were 
transfected with indicated combinations of the Hippo core kinase complex components (Myc-
Lats2, HA-Mst2, Flag-WW45, Flag-Mob1A) in the presence or absence of Flag-LIMD1. Levels 
of active Lats2 (pT1041 Lats2 or pS872 Lats2) were determined by Western blot and 
phosphorylated Lats2 was quantified relative to total Lats2 in each sample. The amount of 
pT1041 or pS872 Lats2 relative to total Lats2 in the presence or absence of overexpressed 
LIMD1 is indicated below the pT1041 Lats2 panel. 
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Figure 5. LIMD1 does not affect the formation of Lats2-Mob1A or Mst2-WW45 complexes. 
HEK293T cells were transfected with Myc-Lats2 and Flag-Mob1A (A) or Myc-WW45 and HA-
Mst2 (B, C), in the absence or presence of increasing amounts of Flag-LIMD1. Cell lysates were 
immunoprecipitated as indicated and bound products were Western blotted for the presence of 
associated proteins. Input controls (10%) are shown in the left panels.  
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Figure 6. LIMD1 sequesters active Lats2 in the core kinase complex. (A) HEK293T cells 
were transfected with the core Hippo kinase complex (HA-Mst2, Myc-Lats2, Flag-WW45, Flag-
Mob1A) in the absence (lanes 2, 6) or presence of increasing amounts (lanes 3-4, 7-8) of Myc-
LIMD1. Lanes 1 and 5 contained no HA-Mst2 and were negative controls for the anti-HA 
immunoprecipitation. Cell lysates were immunoprecipitated for Mst2 (anti-HA) and bound 
products were Western blotted for associated Lats2, pT1041 Lats2, WW45, Mob1A, and 
LIMD1. For each sample, the amount of Lats2, pT1041 Lats2, and Mob1A in the bound products 
relative to the input was quantified (B-D). For each sample, the amount of pT1041 Lats2 relative 
to total Lats2 in the input controls (left panels) was also quantified (E). Graphs show means +/- 
s.d. from three independent experiments. *P<0.05, **P<0.01.  
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Figure 7. LIM1 and LIM2 domains mediate the physical interaction of LIMD1 with Lats2. 
(A) Diagram of the LIMD1 LIM domain deletion mutants. (B) HEK293T cells were transfected 
with LIMD1 domain mutants and Myc-Lats2. LIMD1 mutants were immunoprecipitated with a 
Flag antibody and probed for associated Lats2 via Western blot. (C) HEK293T cells were 
transfected with Flag-YAP and indicated Flag-LIMD1 mutants. The amount of pS127 YAP 
relative to total YAP in the samples was quantified (D). Graph shows means +/- s.d. from three 
independent experiments. **P<0.01 
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Figure 8. LIM1 and LIM2 domains mediate the physical interaction of LIMD1 with the 
core kinase complex. (A) HEK293T cells were transfected with the core Hippo kinase complex 
components (HA-Mst2, Myc-Lats2, Flag-WW45, Flag-Mob1A) and the indicated Flag-LIMD1 
deletion mutants. Cell lysates were immunoprecipitated for Mst2 (anti-HA) and the bound 
products immunoblotted for associated Lats2, pT1041 Lats2, WW45, Mob1A, and LIMD1 
deletion mutants. Input controls (10%) are shown in the left panels. (B) Quantitation for (A). For 
each sample in (A), the amount of pT1041 Lats2 in the bound products relative to the input was 
quantified. **P<0.01  
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Figure 9. LIM1 and LIM2 domains mediate the functional effect of LIMD1 on the Hippo 
pathway. (A-I) Wings from control (Ctrl) female flies (A), female flies expressing dJub RNAi 
alone (B), or female flies expressing dJub RNAi and HA-hLIMD1 or LIMD1 mutant transgenes 
(C-I). All flies also expressed Dcr. 1096>Gal4 was used to drive expression of dJub RNAi, the 
LIMD1 transgenes, and Dcr. (J) Quantitation of relative wing areas of the genotypes in (A)-(I). 
Area measurements were taken of the whole wing. 8-12 wings were measured per genotype. 
Asterisks indicate genotypes where area measurements were statistically different from the flies 
expressing only the dJub RNAi. **P<0.01.  
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Figure 10. Expression and localization of the LIMD1 transgenic constructs. Wing discs from 
third instar larvae expressing the indicated transgenes were dissected and stained with α-DE-
Cadherin and α-HA antibodies. Identical microscope settings were utilized for all images. 
Relative fluorescence intensity was determined by quantifying the amount of HA signal relative 
to DE-Cadherin signal within a 50 square pixel area. 4-7 discs were quantified per genotype. 
*P<0.5  
0!
0.2!
0.4!
0.6!
0.8!
1!
1.2!
1.4!
hL
IM
D1
!
ΔL
IM
2/
3!
ΔL
IM
1/
3!
ΔL
IM
1/
2!
ΔL
IM
1!
ΔL
IM
2!
ΔL
IM
3!R
el.
 A
m
t. 
HA
 F
luo
re
sc
en
ce
 In
te
ns
ity
!
* 
* 
Figure 10 
80 
1096>ΔLIM1!
1096>ΔLIM2!
1096>ΔLIM3!
1096>ΔLIM1/2!
1096>ΔLIM1/3!
1096>ΔLIM2/3!
1096>hLIMD1!
DE-Cad!
DE-Cad!
HA!
HA!
Merge!
Merge!
DE-Cad! HA! Merge!
DE-Cad! HA! Merge!
DE-Cad! HA! Merge!
DE-Cad! HA! Merge!
DE-Cad! HA! Merge!
DE-Cad! HA! Merge!
Ctrl!
	  
	  
81 
Figure 11. LIMD1 inhibits the association of active Lats2 with its target, YAP. HEK293T 
cells were transfected with Flag-YAP and the Hippo complex components (HA-Mst2, Myc-
Lats2, Flag-WW45, and Flag-Mob1A) with or without Flag-LIMD1 (lanes 2-3, 5-6). Lanes 1 
and 4 contained no Myc-Lats2 and were negative controls for the Myc immunoprecipitation. Cell 
lysates were immunoprecipitated with Lats2 (anti-Myc) and bound products immunoblotted for 
YAP, Mst2, WW45, Mob1A, and LIMD1. For each sample, the amount of YAP and Mst2 in the 
bound products relative to the input was quantified (shown in the graphs). Values are means +/- 
s.d. from three independent experiments. **P<0.01.   
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Figure 12. Model of the effect of subcellular localization on Ajuba LIM-mediated inhibition 
of the Hippo pathway. Schematic of a model for the density-dependent effect of Ajuba and 
LIMD1 on Hippo pathway activity. 
 
  
Figure 12 
84 
	  
	  
85 
References 
Abe, Y., Ohsugi, M., Haraguchi, K., Fujimoto, J., and Yamamoto, T. (2006). LATS2-Ajuba 
complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during 
mitosis. FEBS Lett 580, 782-788. 
Bao, Y., Sumita, K., Kudo, T., Withanage, K., Nakagawa, K., Ikeda, M., Ohno, K., Wang, Y., 
and Hata, Y. (2009). Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of 
Mps one binder 1B in the activation of nuclear Dbf2-related kinases. Genes Cells 14, 1369-1381. 
Camargo, F.D., Gokhale, S., Johnnidis, J.B., Fu, D., Bell, G.W., Jaenisch, R., and 
Brummelkamp, T.R. (2007). YAP1 increases organ size and expands undifferentiated progenitor 
cells. Curr Biol 17, 2054-2060. 
Chan, E.H.Y., Nousiainen, M., Chalamalasetty, R.B., Schäfer, A., Nigg, E.A., and Silljé, H.H.W. 
(2005). The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. 
Oncogene 24, 2076-2086. 
Chan, S.W., Lim, C.J., Loo, L.S., Chong, Y.F., Huang, C., and Hong, W. (2009). TEADs 
mediate nuclear retention of TAZ to promote oncogenic transformation. The Journal of 
biological chemistry 284, 14347-14358. 
Das Thakur, M., Feng, Y., Jagannathan, R., Seppa, M.J., Skeath, J.B., and Longmore, G.D. 
(2010). Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway. Curr 
Biol. 
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S.A., Gayyed, M.F., Anders, 
R.A., Maitra, A., and Pan, D. (2007). Elucidation of a universal size-control mechanism in 
Drosophila and mammals. Cell 130, 1120-1133. 
Feng, Y., Zhao, H., Luderer, H.F., Epple, H., Faccio, R., Ross, F.P., Teitelbaum, S.L., and 
Longmore, G.D. (2007). The LIM protein, Limd1, regulates AP-1 activation through an 
interaction with Traf6 to influence osteoclast development. The Journal of biological chemistry 
282, 39-48. 
Guo, C., Tommasi, S., Liu, L., Yee, J.-K., Dammann, R., and Pfeifer, Gerd P. (2007). RASSF1A 
Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network. 
Current Biology 17, 700-705. 
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., 
and Halder, G. (2006). The tumour-suppressor genes NF2/Merlin and Expanded act through 
Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 8, 27-36. 
Harvey, K.F., Pfleger, C.M., and Hariharan, I.K. (2003). The Drosophila Mst ortholog, hippo, 
restricts growth and cell proliferation and promotes apoptosis. Cell 114, 457-467. 
	  
	  
86 
Hergovich, A., Schmitz, D., and Hemmings, B.A. (2006). The human tumour suppressor LATS1 
is activated by human MOB1 at the membrane. Biochem Biophys Res Commun 345, 50-58. 
Huang, J., Wu, S., Barrera, J., Matthews, K., and Pan, D. (2005). The Hippo signaling pathway 
coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila 
Homolog of YAP. Cell 122, 421-434. 
Ikeda, M., Kawata, A., Nishikawa, M., Tateishi, Y., Yamaguchi, M., Nakagawa, K., 
Hirabayashi, S., Bao, Y., Hidaka, S., Hirata, Y., et al. (2009). Hippo pathway-dependent and -
independent roles of RASSF6. Sci Signal 2, ra59. 
Justice, R.W., Zilian, O., Woods, D.F., Noll, M., and Bryant, P.J. (1995). The Drosophila tumor 
suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required 
for the control of cell shape and proliferation. Genes Dev 9, 534-546. 
Kango-Singh, M., Nolo, R., Tao, C., Verstreken, P., Hiesinger, P.R., Bellen, H.J., and Halder, G. 
(2002). Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. 
Development 129, 5719-5730. 
Kim, N.-G., Koh, E., Chen, X., and Gumbiner, B.M. (2011). E-cadherin mediates contact 
inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci 
USA 108, 11930-11935. 
Lee, J.-H., Kim, T.-S., Yang, T.-H., Koo, B.-K., Oh, S.-P., Lee, K.-P., Oh, H.-J., Lee, S.-H., 
Kong, Y.-Y., Kim, J.-M., et al. (2008). A crucial role of WW45 in developing epithelial tissues 
in the mouse. EMBO J 27, 1231-1242. 
Liu, C.-Y., Zha, Z.-Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S.W., Lim, C.J., 
Hong, W., et al. (2010). The hippo tumor pathway promotes TAZ degradation by 
phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. The Journal of 
biological chemistry 285, 37159-37169. 
Lu, L., Li, Y., Kim, S.M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M.J., 
Lee, J.-S., et al. (2010). Hippo signaling is a potent in vivo growth and tumor suppressor 
pathway in the mammalian liver. Proc Natl Acad Sci USA. 
Luo, X., Li, Z., Yan, Q., Li, X., Tao, D., Wang, J., Leng, Y., Gardner, K., Judge, S.I.V., Li, Q.Q., 
et al. (2009). The human WW45 protein enhances MST1-mediated apoptosis in vivo. Int J Mol 
Med 23, 357-362. 
Marie, H., Pratt, S.J., Betson, M., Epple, H., Kittler, J.T., Meek, L., Moss, S.J., Troyanovsky, S., 
Attwell, D., Longmore, G.D., et al. (2003). The LIM protein Ajuba is recruited to cadherin-
dependent cell junctions through an association with alpha-catenin. The Journal of biological 
chemistry 278, 1220-1228. 
McClatchey, A.I., and Yap, A.S. (2012). Contact inhibition (of proliferation) redux. Curr Opin 
Cell Biol 24, 685-694. 
	  
	  
87 
Murugan, P., Sarkeshik, A., Yates, J.R., and McCollum, D. (2011). Angiomotin family proteins 
are novel activators of the LATS2 kinase tumor suppressor. Molecular biology of the cell. 
Nola, S., Daigaku, R., Smolarczyk, K., Carstens, M., Martin-Martin, B., Longmore, G., Bailly, 
M., and Braga, V.M.M. (2011). Ajuba is required for Rac activation and maintenance of E-
cadherin adhesion. J Cell Biol 195, 855-871. 
Ota, M., and Sasaki, H. (2008). Mammalian Tead proteins regulate cell proliferation and contact 
inhibition as transcriptional mediators of Hippo signaling. Development 135, 4059-4069. 
Pantalacci, S., Tapon, N., and Léopold, P. (2003). The Salvador partner Hippo promotes 
apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 5, 921-927. 
Polesello, C., Huelsmann, S., Brown, N.H., and Tapon, N. (2006). The Drosophila RASSF 
homolog antagonizes the hippo pathway. Curr Biol 16, 2459-2465. 
Praskova, M., Xia, F., and Avruch, J. (2008). MOBKL1A/MOBKL1B phosphorylation by MST1 
and MST2 inhibits cell proliferation. Curr Biol 18, 311-321. 
Rauskolb, C., Pan, G., Reddy, B.V.V.G., Oh, H., and Irvine, K.D. (2011). Zyxin links fat 
signaling to the hippo pathway. PLoS Biol 9, e1000624. 
Song, H., Mak, K.K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., 
Simpson, R.M., et al. (2010). Mammalian Mst1 and Mst2 kinases play essential roles in organ 
size control and tumor suppression. Proc Natl Acad Sci USA 107, 1431-1436. 
St John, M.A., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M.L., Brownstein, D.G., Parlow, 
A.F., McGrath, J., and Xu, T. (1999). Mice deficient of Lats1 develop soft-tissue sarcomas, 
ovarian tumours and pituitary dysfunction. Nat Genet 21, 182-186. 
Sudol, M., and Harvey, K.F. (2010). Modularity in the Hippo signaling pathway. Trends 
Biochem Sci 35, 627-633. 
Tapon, N., Harvey, K.F., Bell, D.W., Wahrer, D.C.R., Schiripo, T.A., Haber, D.A., and 
Hariharan, I.K. (2002). salvador Promotes both cell cycle exit and apoptosis in Drosophila and is 
mutated in human cancer cell lines. Cell 110, 467-478. 
Udan, R.S., Kango-Singh, M., Nolo, R., Tao, C., and Halder, G. (2003). Hippo promotes 
proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 5, 914-920. 
Varelas, X., Samavarchi-Tehrani, P., Narimatsu, M., Weiss, A., Cockburn, K., Larsen, B.G., 
Rossant, J., and Wrana, J.L. (2010). The Crumbs Complex Couples Cell Density Sensing to 
Hippo-Dependent Control of the TGF-β-SMAD Pathway. Dev Cell 19, 831-844. 
Vassilev, A., Kaneko, K.J., Shu, H., Zhao, Y., and DePamphilis, M.L. (2001). TEAD/TEF 
transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein 
localized in the cytoplasm. Genes Dev 15, 1229-1241. 
	  
	  
88 
Visser, S., and Yang, X. (2010). LATS tumor suppressor: A new governor of cellular 
homeostasis. Cell Cycle 9, 3892-3903. 
Wang, Y., Dong, Q., Zhang, Q., Li, Z., Wang, E., and Qiu, X. (2010). Overexpression of yes-
associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. 
Cancer science. 
Wu, S., Huang, J., Dong, J., and Pan, D. (2003). hippo encodes a Ste-20 family protein kinase 
that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. 
Cell 114, 445-456. 
Xu, M.Z., Yao, T.-J., Lee, N.P.Y., Ng, I.O.L., Chan, Y.-T., Zender, L., Lowe, S.W., Poon, 
R.T.P., and Luk, J.M. (2009). Yes-associated protein is an independent prognostic marker in 
hepatocellular carcinoma. Cancer 115, 4576-4585. 
Xu, T., Wang, W., Zhang, S., Stewart, R.A., and Yu, W. (1995). Identifying tumor suppressors 
in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 
121, 1053-1063. 
Yang, N., Morrison, C.D., Liu, P., Miecznikowski, J., Bshara, W., Han, S., Zhu, Q., Omilian, 
A.R., Li, X., and Zhang, J. (2012). TAZ induces growth factor-independent proliferation through 
activation of EGFR ligand amphiregulin. Cell Cycle 11, 2922-2930. 
Zhang, J., Ji, J.-Y., Yu, M., Overholtzer, M., Smolen, G.A., Wang, R., Brugge, J.S., Dyson, N.J., 
and Haber, D.A. (2009). YAP-dependent induction of amphiregulin identifies a non-cell-
autonomous component of the Hippo pathway. Nat Cell Biol 11, 1444-1450. 
Zhang, K., Rodriguez-Aznar, E., Yabuta, N., Owen, R.J., Mingot, J.M., Nojima, H., Nieto, M.A., 
and Longmore, G.D. (2012). Lats2 kinase potentiates Snail1 activity by promoting nuclear 
retention upon phosphorylation. EMBO J 31, 29-43. 
Zhang, N., Bai, H., David, K.K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, 
R.A., and Pan, D. (2010). The Merlin/NF2 tumor suppressor functions through the YAP 
oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 19, 27-38. 
Zhao, B., Li, L., Lu, Q., Wang, L.H., Liu, C.-Y., Lei, Q., and Guan, K.-L. (2011). Angiomotin is 
a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25, 51-63. 
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., and Guan, K.-L. (2010). A coordinated 
phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 
24, 72-85. 
Zhao, B., Wei, X., Li, W., Udan, R.S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. 
(2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact 
inhibition and tissue growth control. Genes Dev 21, 2747-2761. 
	  
	  
89 
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J.D., Wang, C.-Y., Chinnaiyan, A.M., 
et al. (2008). TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 
22, 1962-1971. 
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G.Y., Thasler, W., Lee, 
J.T., Avruch, J., et al. (2009). Mst1 and Mst2 maintain hepatocyte quiescence and suppress 
hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 
16, 425-438. 
 
 
90 
 
 
 
 
 
 
 
Chapter 3 
Role of subcellular localization in the regulation of the Hippo pathway 
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Introduction 
 Accumulating evidence in both flies and mammalian cells suggests that the subcellular 
localization of the core Hippo kinase complex is important for its activation. In Drosophila, 
over-expressed wild-type Mats, which is predominantly cytoplasmic, has no effect on organ size 
or tissue growth; however, targeting Mats to the plasma membrane results in increased Wts 
activation and inhibition of proliferation (Ho et al., 2009). Likewise, targeting Hpo to the plasma 
membrane enhances its dimerization, which in turn increases its autophosphorylation (Deng et 
al., 2013). Several polarity complex proteins have been identified as regulators of Hippo 
signaling. One such polarity regulator, aPKC, inhibits Hippo pathway signaling by causing the 
mislocalization of Hippo in the cytosol instead of at the plasma membrane (Grzeschik et al., 
2010; Parsons et al., 2010). Similarly, in mammals, targeting Mob1 to the plasma membrane 
recruits Lats to the plasma membrane and enhances its activation (Hergovich et al., 2006). 
 The mechanism by which the Hippo core kinase complex is recruited to the plasma 
membrane is not well understood. In Drosophila, the upstream regulatory Kibra/Ex/Mer (KEM) 
complex is membrane associated and can bind and recruit Hippo when overexpressed in S2 cells 
(Yu et al., 2010). Similarly, targeting Ex to the plasma membrane can recruit Wts and lead to 
Wts activation. In the absence of forced recruitment of Ex to the plasma membrane, Ex has been 
shown to bind to the apical transmembrane protein Crumbs (Crb), which likewise enhances Wts 
activation (Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010). The equivalent 
complex in mammalian cells, the KM complex consisting of Kibra and NF2/Merlin, is less well-
studied. However, there is evidence that this complex can associate with and activate Lats 
(Genevet et al., 2010; Xiao et al., 2011). 
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 Junctional proteins have also been implicated in the regulation of the Hippo pathway. 
Disruption of adherens junctions, by low calcium or by depletion of E-cadherin or β-catenin, can 
increase the nuclear localization of YAP in epithelial monolayers (Kim et al., 2011; Varelas et 
al., 2010). In addition, the tight junction protein AMOT has been shown to directly associate 
with YAP, which may contribute to the sequestration of YAP in the cytosol (Chan et al., 2011; 
Zhao et al., 2011). Consistent with this, YAP has been visualized by immunofluorescence at 
points of cell-cell contact in confluent cultures. AMOT can also physically associate with Lats 
and enhance its activation, leading to speculation that the tight junctions may provide a scaffold 
for Lats-mediated phosphorylation of YAP (Murugan et al., 2011). In addition, the Drosophila 
nectin-like protein, Echinoid, was recently shown to contribute to Hippo pathway activation by 
physically associating with Sav and recruiting it to adherens junctions (Yue et al., 2012). 
 Much like the components of the Hippo pathway, the Ajuba LIM proteins also occupy 
multiple subcellular compartments. They are found at adherens junctions, where they interact 
with the adherens junction protein α-catenin via their LIM domains (Marie et al., 2003). This 
interaction is important for the maturation and strength of the adherens junctions, since depletion 
of Ajuba in epithelial cells leads to a decrease in cadherin-cadherin bond strength (Das Thakur, 
2010; Marie et al., 2003). When adherens junctions in epithelial monolayers are disrupted by low 
calcium, Ajuba is displaced from the plasma membrane and accumulates in the cytosol (Marie et 
al., 2003) (Fig. 1). Restoration of adherens junctions by the re-addition of calcium results in a 
restoration of Ajuba to the plasma membrane. In addition, the Ajuba LIM proteins contain a NES 
in the Prelim region and actively shuttle between the cytosol and the nucleus. In the nucleus, 
Ajuba associates with Snail as a co-repressor to down-regulate E-cadherin and promote EMT 
(Langer et al., 2008). Nuclear Ajuba also regulates differentiation of embryonal cells, in a Jnk-
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mediated process (Kanungo et al., 2000). In the cytoplasm, the Ajuba LIM proteins have been 
shown to enhance MAPK activation via an association with Grb2 (Goyal et al., 1999). The 
ability of the Ajuba LIM proteins to shuttle between the nucleus, cytoplasm, and plasma 
membrane suggests that they could be involved in coordinating cellular processes across 
subcellular compartments. 
 Our work in Chapter 2 demonstrated a cell density-dependent role for the Ajuba LIM 
proteins in regulating the Hippo pathway. We hypothesize that the restriction of Ajuba LIM-
mediated Hippo pathway inhibition to low density cells, when the Ajuba LIM proteins are 
cytosolic, may reflect a role for subcellular localization in this regulation. To test this, we 
alternately forced the complex and LIMD1 to occupy different subcellular compartments and 
determined the effect on complex formation. We found that, while targeting the complex to the 
plasma membrane did enhance its activation as reported, this membrane targeted complex was 
not inhibited by the Ajuba LIM proteins. However, our data suggested that membrane-
localization of the Hippo core kinase complex was not a prerequisite for activation. Conversely, 
membrane-targeted LIMD1 was unable to bind to or enhance the association of the wild-type 
core kinase complex. These results confirmed that subcellular localization did in fact regulate 
Ajuba LIM-mediated inhibition of the Hippo pathway and established a mechanism by which 
cell density information could be conveyed to intracellular regulatory processes.  
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Results 
LIMD1 did not inhibit the membrane-targeted core kinase complex 
 Several studies have suggested that plasma membrane localization of the Hippo pathway 
components is important for their activation. The Ajuba LIM proteins are recruited to the plasma 
membrane when epithelial cells form adherent epithelial sheets, while in proliferating non-
contacted cells, Ajuba LIM proteins are cytosolic (Marie et al., 2003). Since the Hippo pathway 
is activated when cells are in contact with one another, this suggested the possibility that the 
Ajuba LIM proteins inhibit Hippo pathway activity in low density, proliferating cells by 
sequestering active Lats2 in a complex with other Hippo core complex components in the 
cytosol. When cells are at high density, the Hippo core kinase complex and Ajuba LIM proteins 
are recruited to regions of cell-cell contact where Ajuba LIM proteins are no longer able to 
associate with and inhibit the Hippo complex, thus resulting in increased Hippo activity.  
To test this possibility we first asked where components of the endogenous Hippo core 
kinase complex localize in MCF10A cells grown at low or high density. Lats1, WW45, Ajuba 
and LIMD1 were all predominantly cytosolic in cells at low density (Fig. 2). However, when 
MCF10A cells formed confluent epithelia (i.e. high density) Lats1, WW45, Ajuba, and LIMD1 
all localized to regions of cell-cell contact (Fig. 2). Due to limitations inherent to available 
antibodies, we were unable to detect endogenous Mst2 or Mob1 in these cells by 
immunofluorescence. 
 To determine whether plasma membrane recruitment of the Hippo complex would 
prevent LIMD1-mediated inhibition, we contrasted the extent of Hippo complex association in 
HEK293T cells expressing a membrane-targeted isoform of Mob1A, mp-Mob1A, in the absence 
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or presence of LIMD1, versus cells transfected with wild-type Mob1A. This Mob1A mutant has 
been shown to constitutively localize Lats1 to the plasma membrane and activate Lats1 
(Hergovich et al., 2005; Hergovich et al., 2006). Consistent with previous reports, mp-Mob1A, 
efficiently activated Lats2 when overexpressed in HEK293T cells (Fig. 3A); however, in contrast 
to HEK293T cells transfected with wild-type Mob1A, where LIMD1 inhibited Lats2 activity, in 
HEK293T cells expressing mp-Mob1A, LIMD1 no longer inhibited activation of Lats2 (Fig. 
3A). To determine whether LIMD1 could associate with the membrane-targeted Hippo core 
complex, we immunoprecipitated Mst2 from cells expressing wild-type Mob1A or mp-Mob1A 
and Western blotted for indicated proteins in the bound products (Fig. 3A). LIMD1 efficiently 
associated with the complex in cells expressing wild-type Mob1A, but did not co-
immunoprecipitate with the Mst2-associated core complex in cells transfected with mp-Mob1A 
(Fig. 3A). Furthermore, while LIMD1 increased the association of active Lats2 with the wild-
type core complex, the addition of LIMD1 to the membrane-targeted core complex did not 
further enhance the association of active Lats2 with the complex (Fig. 3B). These results 
suggested that LIMD1 only inhibited the Hippo pathway in low density, proliferating cells by 
binding to and enhancing the association of the core kinase complex in the cytosol. 
Hippo pathway activation is not dependent on recruitment of the complex to the plasma 
membrane 
 The finding that the Ajuba LIM proteins could only associate with the core kinase 
complex in the cytosol raised the question of whether plasma membrane recruitment of the 
Hippo core complex was a prerequisite for its activation, or if membrane recruitment represented 
just one of many mechanisms by which the Hippo pathway could be activated. We previously 
observed that depletion of Ajuba and LIMD1 from MCF10A cells at low density resulted in 
96 
 
increased Hippo pathway activity, as measured by YAP phosphorylation, transcriptional activity, 
and subcellular localization (Chapter 2, Fig. 2). If membrane localization of the Hippo pathway 
were required for Hippo activity, we would predict that Lats1 would be recruited to the plasma 
membrane in low density MCF10A cells depleted of Ajuba and LIMD1. Instead, Lats1 remained 
cytosolic in low density MCF10A cells depleted of Ajuba and LIMD1 (Fig. 4). Furthermore, 
depletion of Ajuba and LIMD1 in high density MCF10A cells, in which density-dependent 
Hippo activation was intact (Chapter 2, Fig. 2), also showed a loss of Lats1 recruitment to the 
plasma membrane (Fig. 4). These data indicated that membrane recruitment of the core kinase 
complex was not a prerequisite for Hippo pathway activation. Furthermore, it suggested that 
intact, mature adherens junctions may be required for normal recruitment of the complex 
components to the plasma membrane, since Ajuba LIM depletion has been shown to negatively 
impact adherens junction formation (Marie et al., 2003; Nola et al., 2011).  
 Disruption of adherens junctions, by depletion of E-cadherin or β-catenin, can inhibit 
Hippo pathway activity, as indicated by an increase in YAP nuclear localization in high density 
epithelia (Kim et al., 2011). To determine the role of adherens junctions in cell density-sensing 
and recruitment of Lats1 and WW45 to plasma membranes, we disrupted adherens junctions in 
MCF10A cells by using shRNA to deplete these cells of α-catenin. As expected, depletion of α-
catenin precluded the formation of intact adherens junctions, as shown by a loss of E-cadherin 
staining at membranes in high density cultures (Fig. 5A). We then tested the responsiveness of 
the Hippo pathway in these α-catenin depleted cells to cell density. To do so, we utilized a 
TEAD-responsive luciferase reporter (Ota and Sasaki, 2008) and measured luciferase activity in 
wild-type and α-catenin-depleted cells grown at low and high density. Interestingly, cells 
depleted of α-catenin displayed higher YAP transcriptional activity at both low and high density, 
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as compared to wild-type MCF10A cells at similar densities (Fig. 5B). However, even in the 
absence of α-catenin, these cells displayed a decrease in YAP activity with cell density that was 
proportionate with the decrease in YAP activity seen in wild-type MCF10A cells with increased 
density (Fig. 5B), suggesting that Hippo pathway activation by cell density was intact, even in 
the absence of adherens junctions. As such, we hypothesized that, if membrane localization were 
required for Hippo pathway activity, disruption of adherens junction should not disrupt, or 
should only minimally disrupt, Lats1 and WW45 localization to the plasma membrane in 
response to high density. To test this, we used MCF10A cells depleted of α-catenin and 
visualized Lats1 and WW45 localization at low and high density by immunofluorescence. 
Interestingly, Lats1 and WW45 were not recruited to plasma membranes in the absence of α-
catenin, at either low or high density (Fig. 5A). These data suggested that, while membrane 
recruitment of the core complex was sufficient to activate the pathway, it was not necessary. 
Other mechanisms must exist that convey density information to the core kinase complex and 
induce its activation in the cytoplasm of cells in which, due to disruption of adherens junctions, 
membrane recruitment is not possible.  
Membrane-targeting LIMD1 abrogated its inhibition of the Hippo pathway 
While our results suggested that the subcellular localization of the Hippo pathway 
complex was important for, but not critical to, its activation in response to cell density, it was not 
clear what role subcellular localization played in Ajuba LIM-mediated inhibition of the pathway. 
To address the role of the subcellular localization of the Ajuba LIM proteins in Hippo pathway 
regulation, we generated a LIMD1 construct containing the CAAX motif from human KRas, to 
target it to the plasma membrane (Fig. 6A). Overexpressed wild-type LIMD1, in contrast, was 
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predominantly cytoplasmic at both low density and at high density (Fig. 6A), in contrast to 
endogenous LIMD1, which was recruited to junctions at high density (Fig. 2).  
To determine whether targeting LIMD1 to the plasma membrane affected the Hippo 
pathway, we overexpressed wild-type or LIMD1-CAAX along with YAP in HEK293T cells and 
asked what effect they each had on YAP phosphorylation. Wild-type LIMD1, as expected, 
inhibited YAP phosphorylation (Fig. 6B, lane 2). However, LIMD1-CAAX was unable to inhibit 
YAP phosphorylation, despite being efficiently expressed in the HEK293T cells (Fig. 6B, lane 
3). To exclude the possibility that LIMD1-CAAX was unable to inhibit YAP phosphorylation 
because it was misfolded, we overexpressed Lats2 along with the targeted LIMD1 constructs, 
immunoprecipitated LIMD1 and Western blotted for Lats2 in the bound products. Both wild-
type LIMD1 and LIMD1-CAAX were able to bind Lats2, indicating that they were correctly 
folded (Fig. 6C).  
 We then asked whether LIMD1 targeted to the plasma membrane was able to associate 
with and enhance active Lats binding with the core kinase complex. To test this, we 
overexpressed the core kinase complex components in the presence of either wild-type LIMD1 
or LIMD1-CAAX. In contrast to wild-type LIMD1, LIMD1-CAAX did not co-
immunoprecipitate with the Mst2-associated core kinase complex, and only minimally enhanced 
the association of active Lats2 with the core kinase complex (Fig. 7). These data indicated that 
LIMD1 at the plasma membrane was unable to associate with or recruit the Hippo core kinase 
complex, consistent with our observation that membrane-targeted LIMD1 was unable to inhibit 
YAP phosphorylation. 
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Discussion 
 While Ajuba LIM proteins and Hippo pathway complex components both localized to the 
cytosol at low density and the plasma membrane at high density, the Ajuba LIM proteins 
physically interacted with and inhibited the Hippo pathway only in low density cells. This 
suggested that the mechanisms recruiting the Ajuba LIM proteins and the Hippo pathway 
components to the plasma membrane at high density are distinct. While the mechanisms 
underlying Ajuba recruitment to the membrane have been established, it is unclear how the core 
complex is brought to the membrane and why membrane association enhances its activation.  
One possibility is that the plasma membrane simply provides a scaffold to enhance the 
efficiency of complex assembly and activation. Alternatively, it is possible that some other 
positive regulator of the complex is constitutively present at the membrane and, as a result, 
recruits and/or activates the complex there. However, our results suggested that, while membrane 
localization may be one method for enhancing Hippo pathway activity, it was not required and 
may not be the only way of stimulating Hippo signaling. For example, several labs have recently 
reported a role for cytoskeletal components and intracellular tension in the regulation of the 
Hippo pathway (Dupont et al., 2011; Sansores-Garcia et al., 2011; Wada et al., 2011). While the 
reports are split on whether this method of pathway activation requires Mst or not, they suggest 
that Lats may be able to associate directly with the actin cytoskeleton. In the absence of 
membrane localization, the cytoskeleton could thus provide a scaffold for complex assembly and 
Lats activation. 
It has been postulated that the Ajuba LIM proteins regulate adherens junction stability by 
linking α-catenin with the actin cytoskeleton (Marie et al., 2003; Nola et al., 2011). Depletion of 
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the Ajuba LIM proteins weakens adherens junctions, leading to defects in cell-cell adhesion 
strength. Lats has been shown to physically associate with the tight junction protein, AMOT, as 
well as with the apical polarity protein, Crumbs. Thus, these molecules, or other tight junctional 
or polarity complex proteins could be responsible for recruiting Lats to the plasma membrane in 
contexts where membrane recruitment is involved in pathway activation. This model could 
explain why disruption of adherens junctions, by depletion of α-catenin or the Ajuba LIM 
proteins, disrupts Lats and WW45 recruitment to the plasma membrane. Adherens junctions are 
critical for organizing apical-basal polarity, since tight junctions do not form in the absence of 
adherens junctions and apical polarity proteins are mislocalized (Das Thakur, 2010; Nelson, 
2003). 
The density-dependent regulation of the Hippo pathway by the Ajuba LIM proteins suggested 
that their subcellular localization may be important for their ability to associate with and inhibit 
the Hippo core kinase complex. Our results indicated that the Ajuba LIM proteins were only able 
to inhibit the Hippo pathway when they were cytoplasmic, since membrane-targeted LIMD1 was 
unable to enhance the association of the core kinase complex. This supported our hypothesis that 
the Ajuba LIM proteins do not regulate Hippo pathway signaling at high density because they 
are associated with adherens junctions. This suggests that disruption of adherens junctions, 
which displaces Ajuba LIM proteins from the membrane, would increase the inhibition of the 
Hippo core kinase complex. Consistent with this hypothesis, we found that depletion of α-catenin 
decreased Hippo pathway activity proportionately at both low and high density. Future 
experiments, focused on the effect of Ajuba LIM depletion on Hippo pathway signaling/YAP 
phosphorylation in cells lacking α-catenin, would address the question of whether the increased 
YAP activity associated with adherens junction disruption is due to an increase in cytoplasmic 
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Ajuba and LIMD1, or whether it reflects some intrinsic role of cell-cell adhesion on density 
sensing and YAP activity.  
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Materials and Methods 
Cell culture and transfections 
MCF10A cells were cultured in 1:1 DMEM/F12 (Gibco) supplemented with 5% heat-
inactivated horse serum (Gibco), 100ng/mL Cholera toxin, 10µg/mL insulin, 20ng/mL EGF, 
500ng/mL hydrocortisone, 200µM L-glutamine (Cellgro), and penicillin/streptomycin (Gibco). 
MDCK cells were cultured in 1x MEM Alpha (Gibco) supplemented with 10% heat-inactivated 
FBS (Sigma), 200µM L-glutamine, and penicillin/streptomycin. HEK293T cells were cultured in 
DMEM (Gibco) supplemented with 10% heat-inactivated FBS, 200µM L-glutamine, and 
penicillin/streptomycin.  
 Nucleofection (Amaxa Nucleofection Kit L, Program A-024) was used to transfect 
MDCK cells with indicated plasmids, according to manufacturer’s instructions. Cells were 
immediately plated onto glass coverslips at low and high density. Forty-eight hours post-
transfection, cells were fixed for immunostaining. 
Lipofectamine RNAiMAX (Invitrogen) was used to transfect MCF10A cells with siRNA 
directed against Ajuba and LIMD1, according to manufacturer’s instructions. Cells were plated 
onto glass coverslips at low and high density. Forty-eight hours post-transfection, cells were 
fixed for immunostaining. 
 TransIT-LT1 reagent (Mirus) was used to transfect HEK293T cells with indicated 
plasmids, according to manufacturer’s instructions. 
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TEAD-luciferase reporter experiments 
 For TEAD-luciferase experiments, the TEAD-luciferase lentiviral vector was transfected, 
along with packaging plasmids, into HEK293T cells. Media was changed twenty-four hours 
post-transfection. Viral supernatant was collected twenty-four hours after the media change, 
filtered through a 0.45µm filter, and used to infect plated MCF10A cells. Infections were done in 
the presence of 10µg/mL protamine sulfate. Forty-eight hours post-infection, MCF10A cells 
were subject to selection with 10µg/mL blasticidin for four days. Stable clones were pooled and 
maintained in 2.5µg/mL blasticidin. 
 MCF10A cells stably expressing the TEAD-luciferase reporter were then infected with 
lentivirus containing a short hairpin for α-catenin, as described above. Forty-eight hours post-
infection, cells were subject to selection with 3µg/mL puromycin for 2 days. Control MCF10A 
cells and those depleted of α-catenin were plated on black-walled 24-well plates at low and high 
density. 48 hours later, D-luciferin was added and luciferase activity was measured. Immediately 
after, cells were trypsinized and counted, and luciferase signal was normalized to cell number.  
Immunoprecipitation, Western blotting and antibodies used 
 Cells were lysed in RIPA buffer (50mM Tris pH 8.0, 150mM NaCl, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS) supplemented with 200nM PMSF, 2µg/mL 
Aprotinin/Leupeptin, 2µM Pepstatin A, 1mM Na3VO4, and 2mM NaF. Lysates were cleared by 
centrifugation at 12,000 rpm for 10 minutes and concentration determined by Bradford assay 
(Bio-Rad). Equal amounts of protein were boiled in SDS sample buffer, resolved by 8% or 10% 
SDS-PAGE and transferred to PVDF membranes (Millipore) in transfer buffer (25mM Tris, 
192mM glycine, 5% methanol). Membranes were blocked with TBST (25mM Tris pH 7.4, 
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150mM NaCl, 2mM KCl, 0.5% Tween-20) containing 5% skim milk powder or BSA and probed 
overnight with indicated primary antibodies. Bound antibodies were detected by HRP-
conjugated secondary antibodies and developed with SuperSignal West Pico or West Femto ECL 
(Pierce). Images were collected on a Bio-Rad ChemiDoc XRS+ and subject to quantification 
using ImageJ software. The following antibodies were used: rabbit α-YAP (Cell Signaling 
#4912, 1:1000), rabbit α-phospho-YAP (Ser127) (Cell Signaling #4911, 1:1000), rabbit α-Mob1 
(Cell Signaling #3863, 1:1000), rabbit α-alpha-E-catenin (Cell Signaling #3236, 1:1000), mouse 
α-Flag M2 (Sigma F3165, 1:1000), mouse α-HA (Sigma H3663, 1:1000), mouse α-Myc 9E10 
(Millipore 05-419, 1:1000). Rabbit α-phospho-Lats2 T1041 (1:250) was from H. Nojima (Osaka 
University, Japan). 
 For immunoprecipitations, cells were lysed in immunoprecipitation (IP) buffer (10mM 
HEPES pH 7.4, 150mM NaCl, 10% glycerol, 1% NP-40) supplemented with 200nM PMSF, 
2µg/mL Aprotinin/Leupeptin, 2µM Pepstatin A, 1mM Na3VO4, and 2mM NaF. Lysates were 
cleared by centrifugation at 12,000 rpm for 10 minutes and concentrations determined by 
Bradford assay (Bio-Rad). Equal amounts of protein were collected, of which 10% was boiled in 
SDS sample buffer and saved as “Input” and the remainder incubated with indicated antibodies, 
with rocking, overnight at 4 degrees. The next day, Protein G-conjugated sepharose beads 
(Sigma) were added to each reaction at 5µL bed volume/200µg lysate and rocked for 1 hour at 4 
degrees. Immunoprecipitates were washed 3 times with 1.5mL IP buffer, followed by 
centrifugation at 100xg for 1 minute. The following antibodies were used: mouse α-HA (Sigma 
H3663). Rabbit α-Myc was provided by A. Shaw (Washington University in St. Louis). 
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Immunostaining 
 Cells plated on glass coverslips were fixed in ice-cold methanol or 4% paraformaldehyde 
(PFA) dissolved in PBS. PFA-fixed cells were permeabilized with 0.2% Triton X-100 in PBS. 
For LIMD1 immunostaining, cells were incubated with 6M Guanidine HCl for 10 minutes at 
room temperature for antigen recovery. All cells were blocked in 5% normal goat serum (NGS) 
for 1 hour at room temperature and incubated with indicated primary antibody, diluted in PBS + 
1% NGS, overnight at 4 degrees. Coverslips were washed 3 times with PBS, then incubated with 
secondary antibody diluted in PBS + 1% NGS for 1 hour at room temperature. Cells were 
mounted in Vectashield mounting medium containing DAPI (Vector Labs). Images were 
collected on a LSM 510 Zeiss confocal microscope using a 40x oil objective. ImageJ was used to 
process the images. The following antibodies were used: rabbit α-Lats1 (Cell Signaling #3477, 
1:500), rabbit α-Ajuba (Cell Signaling #4897, 1:250), rabbit α-LIMD1 (Feng et al., 2007) 
(PVDF-purified, 1:50), mouse α-Flag M2 (Sigma F3165, 1:250), mouse α-Myc 9E10 (Millipore 
05-419, 1:500), mouse α-E-cadherin (BD Biosciences 610182, 1:500). Rabbit α-WW45 (1:500) 
was from G. Pfeifer (Beckman Research Institute of the City of Hope) (Guo et al., 2007). 
Secondary antibodies were Alexa Fluor 488 and 568 (Invitrogen, 1:250). 
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Figure 1. Ajuba is rapidly recruited to newly formed cell-cell contacts in keratinocytes. 
Cells grown in low calcium medium lose cell-cell adhesion and E-cadherin (red) and Ajuba 
(green) proteins are internalized into the cell. Cells from low calcium medium (Column 1) were 
then transferred to standard medium for 5min (Column 2), 15min (Column 3) or 60 min (Column 
4) to induce the formation of cell-cell contacts. Cells were stained for E- cadherin and Ajuba. 
Merged images are shown in the bottom row. (Adapted from: Marie et al., 2003.) 
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Figure 2. Hippo pathway components and the Ajuba LIM proteins are recruited to the 
plasma membrane at high density. MCF10A cells were plated on glass coverslips at low and 
high density and stained for E-cadherin (red) or Hippo pathay/Ajuba LIM proteins (green). 
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Figure 3. LIMD1 does not enhance the association of the membrane-targeted core kinase 
complex. (A) HEK293T cells were transfected with Mst2, Lats2, WW45, and either wild-type or 
membrane-targeted Mob1 (mp-Mob1A), in the presence or absence of overexpressed LIMD1. 
Mst2 was immunoprecipitated and the bound products analyzed by Western blotting. (B) 
Quantitation of the relative amount of active Lats2 associated with the wild-type or membrane-
targeted core kinase complex, in the presence of absence of LIMD1. Values are means +/- s.d. 
from two independent experiments. 
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Figure 4. Depletion of Ajuba and LIMD1 disrupts recruitment of Lats1 to the membrane at 
high density. MCF10A cells were transfected with siRNA oligos to Ajuba and LIMD1, plated at 
low and high density on glass coverslips, and then fixed and stained for E-cadherin (red) and 
Lats1 (green). 
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Figure 5. Disruption of adherens junctions by depletion of α-catenin mislocalizes Lats1 and 
WW45 and increases YAP activity. (1) MCF10A cells were infected with a lentiviral vector 
containing an shRNA to α-catenin. α-catenin-depleted cells were plated at low and high density 
on glass coverslips and then fixed and stained for E-cadherin (red) and Lats1 or WW45 (green). 
(B) α-catenin-depleted and wild-type MCF10A cells expressing a GTIIC- Luciferase TEAD 
reporter (Ota and Sasaki, 2008) were plated at low and high density. Relative luciferase activity, 
normalized to cell number, was an indicator of YAP transcriptional activity. Values are means 
+/- s.d. from three independent experiments. **P<0.01. 
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Figure 6. Membrane-targeted LIMD1 cannot inhibit Hippo pathway activity. (A) MDCK 
cells were infected with wild-type or membrane-targeted LIMD1 (LIMD1-CAAX) and stained 
for Myc to confirm localization. (B) HEK293T cells were transfected with Flag-YAP in the 
presence of either LIMD1 or LIMD1-CAAX. Cell lysates were subject to Western blotting to 
determine the amount of YAP phosphorylation at S127 relative to total YAP. Quantitation of 
relative S127 YAP phosphorylation is shown in the graph. Values are means +/- s.d. from five 
independent experiment. **P<0.01. 
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Figure 7. Membrane-targeted LIMD1 cannot associate with the core kinase complex. 
HEK293T cells were transfected with the core kinase complex components with wild-type or 
membrane-targeted LIMD1. Lysates were immunoprecipitated with Mst2, and bound products 
analyzed by Western blotting. Quantitation of the relative amount of active Lats2 associated with 
Mst2 in the presence or absence of LIMD1 or LIMD1-CAAX are shown in the graph.  
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Chapter 4 
Regulation of Mst2 activity by the Ajuba LIM proteins 
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Introduction 
 Regulation of Mst/Hpo activity occurs via multiple different molecular components. 
Mst2 kinase activity is dependent on autophosphorylation on T180, in the activation loop 
(Praskova et al., 2004). Mst2 binding to WW45 enhances its autoactivation, though the 
underlying mechanism is unknown (Chan et al., 2005; Lee et al., 2008). Another category of 
Mst/Hpo regulators are the Rassf family. There is only one Rassf in flies, dRassf, and this 
molecule inhibits Hpo activation by competing with Sav for binding to Hpo (Polesello et al., 
2006). In mammals, Rassf1A and Rassf5/Nore1 have been shown to activate Hpo activity. 
Rassf1A physically associates with both WW45 and Mst1/2, though its association with WW45 
is enhanced by Mst1/2 (Guo et al., 2007). This binding of Rassf1A with Mst2 increases Mst2 
phosphorylation on T180, though in some cell types, such as HEK293T cells, the increase is only 
seen when Rassf1A is targeted to the plasma membrane (Praskova et al., 2004). Rassf1A-
mediated enhancement of Mst activation is due to Rassf1A preventing Mst dephosphorylation by 
PP2A (Guo et al., 2011). Mammalian Rassf6, on the other hand, forms a tripartite complex with 
WW45 and Mst2 and prevents Mst2 activation (Ikeda et al., 2009). Interestingly, it has higher 
affinity for active Mst2, suggesting that it could promote Mst2 dephosphorylation rather than its 
activation.  
While in flies dJub acts downstream of Hpo, we hypothesized that the Ajuba LIM 
proteins could also affect Hippo signaling by interacting with other molecules that regulate 
Hpo/Mst2 activation. In support of this, we observed that, in addition to regulating complex 
association, the Ajuba LIM proteins also inhibited Lats activation as measured by pT1041 and 
pS872 (Fig. 1). However, it appeared that the regulation of Lats activation was separate from 
complex association since domain mutants that do not rescue the djub RNAi phenotype in flies 
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and do not enhance complex formation in HEK293T cells, such as the ∆LIM1 and ∆LIM2 
mutants (Chapter 2, Figure 5, 6) were still able to inhibit Lats phosphorylation (Fig. 1). This 
suggested to us that perhaps the Ajuba LIM proteins were affecting Lats phosphorylation by 
affecting activation of Mst2.  
Using overexpression in HEK293T cells, we found that the Ajuba LIM proteins inhibited 
Mst2 activation. The Ajuba LIM proteins do not physically associate with Mst, so we assessed 
the association of the Ajuba LIM proteins with other Mst regulators and found that LIMD1 
associated with both Rassf1A and Rassf6. 
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Results 
LIMD1 inhibited the activation of Mst2 
 While studying the mechanism of Ajuba LIM-mediated inhibition of the Hippo pathway, 
we observed that, in addition to affecting complex formation, the Ajuba LIM proteins were also 
able to inhibit Lats activation. However, in our domain mutant analysis, we found that domain 
mutants that could inhibit Lats phosphorylation were not able to enhance complex formation or 
rescue the dJub RNAi phenotype in Drosophila (Fig. 1C; Chapter 2, Fig. 5, 6). Specifically, we 
found that the LIM3 domain was required for inhibiting Lats2 activation, since all the domain 
mutants lacking the LIM3 domain were much less effective at inhibiting pS872 and T1041 
phosphorylation (Fig. 1). The exception was the Prelim domain, which, in spite of the absence of 
the LIM3 domain, efficiently inhibited Lats2 activation (Fig. 1). It is possible that the Prelim 
domain alone and the LIM3 domain are involved in different processes that regulate Lats 
activation, since the Ajuba LIM proteins have been shown to mediate protein-protein interaction 
via both the Prelim and LIM domains (Goyal et al., 1999; Hou et al., 2008; Langer et al., 2008).  
We hypothesized that this discrepancy between Lats activation status and rescue of the 
djub RNAi phenotype may reflect an alternate mechanism by which the Ajuba LIM proteins 
impact the Hippo pathway. One possibility was that the Ajuba LIM proteins inhibited Mst2 
activation by upstream signaling components. To test this, we first assessed whether LIMD1 was 
able to inhibit Mst2 activation. We overexpressed Mst2, with or without WW45, and used a 
pT180 antibody to measure Mst2 activation. We found that co-expression of WW45 increased 
Mst2 phosphorylation on T180, consistent with published reports that WW45 enhances Mst2 
activation (Chan et al., 2005; Lee et al., 2008) (Fig. 2A, lane 1, 3). We then determined the effect 
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of LIMD1 on Mst2 activation in both of these contexts. LIMD1 significantly inhibited Mst2 
phosphorylation on T180 both in the presence and absence of overexpressed WW45 (Fig. 2A, 
lane 2, 4).  
 We next wanted to determine whether the effect of LIMD1 on Mst2 activation was 
correlated with the effect of LIMD1 on Lats activation. To test this, we used the domain mutants 
of LIMD1, overexpressed them in HEK293T cells along with Mst2, and determined the effect of 
the different domain mutants on Mst2 phosphorylation (Fig. 2B). We found that all of the 
LIMD1 domain mutants could partially inhibit Mst2 activation, in contrast to the effect on Lats 
activation (Fig. 2C). However, the mutants lacking a LIM3 domain were less efficient inhibitors 
of Mst2 activation, suggesting that Mst2 phosphorylation may only partially explain the inability 
of these LIMD1 mutants to inhibit Lats activation (Fig. 2C). However, these results did confirm 
that LIMD1 can regulate the upstream kinase, Mst2, which may reflect an alternative arm of 
Hippo pathway regulation. 
LIMD1 physically associated with Rassf6 and Rassf1A 
 To determine functionally how the Ajuba LIM proteins inhibited Mst2 activation, we 
asked whether LIMD1 could associate with any of the upstream regulatory components of the 
Hippo pathway. We have previously shown that LIMD1 can associate with WW45. We also 
tested whether LIMD1 could associate with Rassf6, Rassf1A, and the KM complex protein, 
Kibra (Xiao et al., 2011). Interestingly, LIMD1 could co-immunoprecipitate both Rassf1A and 
Rassf6, but did not associate with Kibra (Fig. 3). Rassf1A contains an N-terminal C1-type zinc 
finger domain, which is similar to a LIM domain. LIM domains are known to be able to mediate 
protein-protein interactions with other LIM domains, so it is possible that the association with 
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Rassf1A is occurring in this fashion. Rassf6 does not have this C1-type zinc finger, although it 
has an RA domain and a SARAH domain. LIM domains, however, are promiscuous protein-
protein interaction modules so LIMD1 and Rassf6 could be associating via a different domain 
(Kadrmas and Beckerle, 2004). 
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Discussion 
 While the primary function of the Ajuba LIM proteins in regulating the Hippo pathway 
and YAP/Yki activity appears to involve modulation of the association of the core kinase 
complex (Chapter 2), we noticed that the effect of the Ajuba LIM proteins on complex 
association was dissociated from their effect on Lats activation. As such, we asked whether the 
Ajuba LIM proteins could affect activation of the upstream kinase, Mst2. In fact, we found that 
LIMD1 did inhibit Mst2 activation, and furthermore, that LIMD1 could physically associate with 
several known modulators of Mst2 activity, including WW45, Rassf1A, and Rassf6. This 
suggested that LIMD1 may affect Mst phosphorylation by affecting the association between 
Mst2 and some of these regulatory components. Future experiments in HEK293T cells will focus 
on determining whether LIMD1 impairs the association of Rassf1A or WW45 with Mst2, or 
enhances the association of Rassf6 with Mst2. Alternatively, LIMD1 could function to 
mislocalize the Mst-WW45-Rassf1A or Mst-WW45-Rassf6 complex, and thereby inhibit its 
activation. 
 While we found that LIMD1 could regulate Mst2 phosphorylation status, we also 
discovered that Mst2 phosphorylation status did not perfectly map to Lats activation, suggesting 
that regulation of Lats2 activation by the Ajuba LIM proteins may involve other components or 
levels of regulation. For example, the LIM3 domain was important for the regulation of Mst2 
phosphorylation, since mutants lacking this domain less efficiently inhibited Mst2 activation. 
However, this domain was much more important for inhibiting Lats2 activation, since those 
mutants lacking the LIM3 domain did not inhibit Lats phsophorylaton at all. This could indicate 
that the LIM3 domain is required for recruiting some as-yet-unidentified component – a 
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phosphatase perhaps – that is also important for mediating the inhibition of Lats2 
phosphorylation status.  
 Since the LIMD1 domains that impaired Mst2 and Lats2 activation were not required for 
complex formation or Yki inactivation, the question remains regarding the functional role of 
LIMD1-mediated inhibition of Mst2 activation. In mammals, several pathways of Lats activation 
and YAP inactivation are thought to occur independently of Mst (Dupont et al., 2011; 
Schlegelmilch et al., 2011), suggesting that this canonical method of Hippo pathway signaling 
may be constrained to particular signals, tissues, or contexts. Alternatively, Mst, Lats, Rassf1A, 
WW45, and the Ajuba LIM proteins have all been associated with the regulation of mitosis (Abe 
et al., 2006; Guo et al., 2007; Yabuta et al., 2007). It is possible that the effect of LIMD1 on 
Mst2 activation is not important for YAP regulation, but may play a role in the regulation of the 
cytokinetic apparatus by these Hippo pathway components.  
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Materials and Methods 
Cell culture and transfections 
HEK293T cells were cultured in DMEM (Gibco) supplemented with 10% heat-
inactivated FBS, 200µM L-glutamine, and penicillin/streptomycin.  
 TransIT-LT1 reagent (Mirus) was used to transfect HEK293T cells with indicated 
plasmids, according to manufacturer’s instructions. 
Immunoprecipitation, Western blotting and antibodies used 
 Cells were lysed in RIPA buffer (50mM Tris pH 8.0, 150mM NaCl, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS) supplemented with 200nM PMSF, 2µg/mL 
Aprotinin/Leupeptin, 2µM Pepstatin A, 1mM Na3VO4, and 2mM NaF. Lysates were cleared by 
centrifugation at 12,000 rpm for 10 minutes and concentration determined by Bradford assay 
(Bio-Rad). Equal amounts of protein were boiled in SDS sample buffer, resolved by 8% or 10% 
SDS-PAGE and transferred to PVDF membranes (Millipore) in transfer buffer (25mM Tris, 
192mM glycine, 5% methanol). Membranes were blocked with TBST (25mM Tris pH 7.4, 
150mM NaCl, 2mM KCl, 0.5% Tween-20) containing 5% skim milk powder or BSA and probed 
overnight with indicated primary antibodies. Bound antibodies were detected by HRP-
conjugated secondary antibodies and developed with SuperSignal West Pico or West Femto ECL 
(Pierce). Images were collected on a Bio-Rad ChemiDoc XRS+ and subject to quantification 
using ImageJ software. The following antibodies were used: mouse α-Flag M2 (Sigma F3165, 
1:1000), mouse α-HA (Sigma H3663, 1:1000), mouse α-Myc 9E10 (Millipore 05-419, 1:1000), 
mouse α-T7 (Novagen 69522, 1:5000), rabbit α-Phospho-Mst1 (T183)/Mst2 (T180) (Cell 
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Signaling #3681, 1:500). Rabbit α-phospho-Lats2 T1041 (1:250), and rabbit α-phospho-Lats2 
S872 (1:250) were from H. Nojima (Osaka University, Japan).  
 For immunoprecipitations, cells were lysed in immunoprecipitation (IP) buffer (10mM 
HEPES pH 7.4, 150mM NaCl, 10% glycerol, 1% NP-40) supplemented with 200nM PMSF, 
2µg/mL Aprotinin/Leupeptin, 2µM Pepstatin A, 1mM Na3VO4, and 2mM NaF. Lysates were 
cleared by centrifugation at 12,000 rpm for 10 minutes and concentrations determined by 
Bradford assay (Bio-Rad). Equal amounts of protein were collected, of which 10% was boiled in 
SDS sample buffer and saved as “Input” and the remainder incubated with indicated antibodies, 
with rocking, overnight at 4 degrees. The next day, Protein G-conjugated sepharose beads 
(Sigma) were added to each reaction at 5µL bed volume/200µg lysate and rocked for 1 hour at 4 
degrees. Immunoprecipitates were washed 3 times with 1.5mL IP buffer, followed by 
centrifugation at 100xg for 1 minute. The following antibodies were used: rabbit α-LIMD1 (Feng 
et al., 2007) (PVDF-purified). 
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Figure 1. Different LIM domains regulate complex formation and Lats2 activation. (A) 
HEK293T cells were transfected with the core kinase complex components and the LIMD1 
domain mutants. Lysates were subject to Western blot for pT1041 and pS872 Lats2, quantitated 
in (B). The samples depicted were also used for the input blot in the immunoprecipitation 
experiment shown in Chapter 2, Figure 5. (C) Table depicting the differential effects of the 
LIMD1 domains on Lats2 phosphorylation and complex formation/rescue of djub RNAi in 
Drosophila. 
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Figure 2. LIMD1 inhibits Mst2 phosphorylation at T180. (A) HEK293T cells were transfected 
with HA-Mst2 and Flag-WW45, with or without Flag-LIMD1, and lysates blotted for pT180 
Mst2 phosphorylation. (B) HEK293T cells were transfected with HA-Mst2 and the LIMD1 
domain mutants. Lysates were analyzed by Western blot for T180 Mst2 phosphorylation, and 
quantification is shown in (C). 
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Figure 3. LIMD1 co-immunoprecipitates Rassf1A and Rassf6, but not Kibra. HEK293T 
cells were transfected with Flag-LIMD1 and either Rassf1A, Rassf6, or Kibra. LIMD1 was 
immunoprecipitated using a LIMD1 antibody (Feng et al., 2007) and bound products analyzed 
by Western blot with indicated antibodies. On the Rassf membrane, the higher molecular weight 
band is Rassf1A, while the lower molecular weight band is Rassf6. 
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The Ajuba LIM proteins are a family of adaptor molecules that regulate cell-cell adhesion 
via an association with cadherin complexes and cytoskeletal components (Marie et al., 2003; 
Nola et al., 2011; Pratt et al., 2005). In addition, the Ajuba LIM proteins have been shown to 
shuttle into the nucleus to regulate differentiation and cell migration via EMT (Hou et al., 2008; 
Kanungo et al., 2000; Langer et al., 2008). As such, we hypothesized that the Ajuba LIM 
proteins could be important for bridging signals from the cell surface with intracellular signaling 
mechanisms. The Ajuba LIM proteins were also shown in Drosophila to regulate cell 
proliferation and organ size determination via a genetic and physical interaction with the Hippo 
pathway (Das Thakur et al., 2010). The Hippo pathway, a kinase cascade, is regulated by cell 
density in mammalian cells (Zhao et al., 2007). At a molecular level, cell adhesion complexes 
and polarity regulators have been implicated in activation of Hippo pathway signaling and 
inhibition of YAP/Yki-mediated proliferation (Genevet and Tapon, 2011; Kim et al., 2011; 
Sopko and McNeill, 2009; Yue et al., 2012). Our work demonstrated that the Ajuba LIM 
proteins, via a physical association with the Hippo core kinase complex, inhibited Hippo 
pathway signaling in a density dependent manner, which was in turn regulated by the subcellular 
localization of both Hippo components and the Ajuba LIM proteins. These data provide a model 
by which information about cell adhesive events and the extracellular environment can be 
transmitted to intracellular signaling components and impact on cell proliferation and organ size. 
These Ajuba LIM-mediated regulatory mechanisms may also be involved in tissue regeneration 
and cancer development, since YAP/Yki has been shown to be involved in both (Dong et al., 
2007; Karpowicz et al., 2010; Shaw et al., 2010). 
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Organ size regulation and the Ajuba LIM set-point 
 One of the open questions in development concerns the underlying mechanism(s) of 
animal size determination. Cell intrinsic and extracellular signals both contribute to final organ 
and animal size in development, and to the type and extent of regeneration in response to injury 
(Kango-Singh and Singh, 2009; Stanger, 2008).  
While upstream regulators of organ size appear to be diverse, they converge on molecular 
mechanisms regulating just two processes: cell size and cell number (Stanger, 2008; Tumaneng 
et al., 2012). Cell size (or cell growth) is determined by the TOR pathway or insulin receptor 
signaling. Cell number is determined by the interplay between cell proliferation and apoptosis, 
and can be regulated by many signaling pathways, including the Hippo pathway. While many of 
the upstream signals – such as circulating factors, cell tension, cell contact, polarity – that 
contribute to organ size determination have been identified, how these signals are transmitted to 
the intracellular effectors are unknown.  
 In this thesis, we presented data suggesting that the Ajuba LIM family of LIM proteins 
may represent a critical link between cell-cell contact and the cessation of proliferation via 
inactivation of YAP. Specifically, we found that the Ajuba LIM proteins negatively regulated 
Hippo signaling but that this inhibition was only present in low density, proliferating cells. The 
Ajuba LIM proteins were in turn inhibited, with regard to their regulation of the Hippo pathway, 
by recruitment to the plasma membrane at high density. 
One possibility suggested by these data is that the Ajuba LIM proteins are the primary 
gatekeepers protecting against inappropriate Hippo activation. This is supported by the fact that 
in MCF10A cells, depletion of Ajuba or LIMD1 alone had very little effect on Hippo pathway 
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signaling, but depletion of both Ajuba and LIMD1 dramatically increased Lats-mediated 
inhibition of YAP (Chapter 2). However, even depletion of both Ajuba and LIMD1 wasn’t as 
effective as cell density at activating the pathway, possibly because the cells still contained 
WTIP. Depletion of all three Ajuba LIM proteins in the MCF10A cells, to determine whether 
that would be as effective as cell density at activating the Hippo pathway, was not possible 
because of cell lethality. This is consistent with the fact that deletion of djub, which is required 
for embryogenesis, is lethal in Drosophila (Das Thakur et al., 2010). An alternative to address 
redundancy within the mammalian Ajuba LIM family, however, would be to deplete WTIP in 
conjunction with either LIMD1 or Ajuba to determine whether depletion of this alternate pair of 
Ajuba LIM proteins was also better at inhibiting YAP activity than loss of Ajuba or LIMD1 
alone. If this were true – if WTIP was functionally redundant with Ajuba and LIMD1 in 
regulating the Hippo pathway – and if simple depletion of the Ajuba LIM family was sufficient 
to induce maximal activation of the Hippo pathway in the absence of other signals, it would 
suggest that the amount of Ajuba LIM protein present in a cell would be sufficient to set the 
extent of YAP activation in that cell. In other words, the amount of cytoplasmic Ajuba LIM 
protein would establish a cell-intrinsic set-point for proliferative potential. Inhibitory cross-talk 
between other upstream regulatory signals and the Ajuba LIM proteins (ex. cell contact-mediated 
recruitment of Ajuba to the plasma membrane) would result in the determination of final organ 
or tissue size.  
If the Ajuba Lim proteins were critical for establishing proliferative set-points, one might 
expect that the levels of Ajuba LIM proteins would be highest in organs where size is determined 
by cell intrinsic mechanisms, such as the liver. However, Ajuba levels are only high in adult 
keratinocytes, brain, and genitourinary apparatus (Goyal et al., 1999). Perhaps Ajuba LIM levels 
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would increase in the liver or intestine in response to injury. Alternatively, injury may result in a 
change in the subcellular localization of the Ajuba LIM proteins, from the plasma membrane to 
the cytosol, to allow for Ajuba LIM-mediated Hippo pathway inhibition. Or perhaps Ajuba LIM 
levels are high in these organs during development, but are downregulated once the organs reach 
adult size. A careful analysis of the spatiotemporal expression of Ajuba LIM proteins in 
mammalian development and in response to injury could provide insight into the role of these 
proteins in organ size determination. 
In flies, dJub overexpression causes organ overgrowth in the wing and eye, two tissues in 
which size cues seem to be encoded in the tissue itself (Das Thakur et al., 2010; Kango-Singh 
and Singh, 2009). It has not been determined whether dJub overexpression has any effect on 
proliferation in other organs, or in regeneration in response to injury. In the fly intestine, for 
example, Yki has been shown to be activated in response to intestinal damage, but whether 
depletion of dJub would impair that regeneration would depend on whether dJub is expressed in 
the fly gut (unknown) and perhaps on its subcellular localization in that context (Karpowicz et 
al., 2010; Shaw et al., 2010).  
The plasma membrane as an activator of Hippo signaling 
 While several studies have implicated the plasma membrane as a positive regulator of 
Hippo signaling (Deng et al., 2013; Hergovich et al., 2006; Ling et al., 2010; Murugan et al., 
2011; Praskova et al., 2004), it is still not clear why localization to the apical surface activates 
the Hippo pathway or whether that localization is a requirement for Hippo activation. Our results 
confirmed previous findings that targeting the Hippo core kinase complex to the membrane can 
lead to its activation (Chapter 3). This may be because the plasma membrane provides a docking 
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surface to promote complex assembly, or it may be that some regulatory component is 
membrane localized. If the latter, we might expect that disrupting membrane localization of the 
complex would be sufficient to prevent Hippo pathway activation. In fact, however, we found 
the opposite. Depleting Ajuba and LIMD1 from MCF10A cells at low density was sufficient to 
activate the Hippo pathway (as measured by YAP phosphorylation), but it did not result in 
recruitment of Lats1 and WW45 to the membrane in sparse cells (Chapter 3). Furthermore, 
depletion of Ajuba and LIMD1 in high density cells, in which the Hippo pathway was efficiently 
activated, actually prevented Lats1 and WW45 from being recruited to the membrane, probably 
due to disrupted adherens junction maturation (Das Thakur, 2010; Nola et al., 2011) (Chapter 3). 
Likewise, in cells with α-catenin depletion, which disrupted cell-cell contacts and prevented 
Lats1 and WW45 recruitment to the plasma membrane at high density, the Hippo pathway was 
still activated in response to density (Chapter 3). These results suggested that mechanisms other 
than membrane recruitment can induce Hippo core complex formation and activation. Consistent 
with this, overexpression of the core complex in HEK293T cells was able to induce robust 
phosphorylation of Lats2, despite being predominantly cytoplasmic.  
One possibility is that cytoskeletal structures can provide a scaffold for complex 
association in the absence of membrane recruitment. This is supported by observations that Mst 
can localize with actin filaments, and that Lats activity is enhanced by increased stress fibers 
(Densham et al., 2009; Wada et al., 2011). In addition, Ajuba can also associate with F-actin, 
possibly as a means of linking α-catenin and adherens junction complexes with the cytoskeleton 
(Nola et al., 2011; Pratt et al., 2005). If such a cytoskeletal complex existed, it would be 
interesting to determine whether this complex could be inhibited by the Ajuba LIM proteins, or 
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if, like the plasma membrane, an actin or microtubule-based docking site for complex assembly 
precludes binding to, and inhibition by, the Ajuba LIM proteins. 
Mechanotransduction and growth factor signaling: alternative mechanisms of Hippo 
pathway activation and the role of the Ajuba LIM proteins 
One of the outstanding questions from this work is whether the mechanism of Ajuba 
LIM-mediated regulation of the Hippo pathway described here is applicable to methods of Hippo 
pathway activation other than cell density or organ size. For example, several recent papers have 
indicated that mechanical forces and cytoskeletal architecture – mechanotransduction – are able 
to affect activation of the Hippo pathway. Specifically, YAP activity, and thus cell proliferation, 
is increased by high extracellular matrix stiffness, cell area (i.e. spread out vs. rounded), and F-
actin content (Dupont et al., 2011; Sansores-Garcia et al., 2011; Wada et al., 2011). Interestingly, 
these mechanical signals may affect YAP activity through both Lats-dependent and independent 
mechanisms (Dupont et al., 2011; Wada et al., 2011). The Ajuba LIM proteins, as α-catenin 
binding proteins, regulate adherens junction maturation, and we hypothesize that this interaction 
underlies the loss of Ajuba LIM-mediated Hippo pathway inhibition in high-density cultures. 
However, even in cells in which adherens junctions have been disrupted, for example by 
depletion of α-catenin, YAP is still inactivated by cell density, suggesting that “contact 
inhibition,” as a process, is not solely regulated by cell-cell contact (Chapter 3). One possibility 
is that changes in cytoskeletal architecture in high density cultures can contribute to density-
mediated Hippo pathway activation. For example, cell area will decrease as cultures become 
more crowded, and this may be accompanied by a decrease in cellular F-actin content, both of 
which would be expected to contribute to YAP inactivation (Schroeder and Halder, 2012). 
Whether the Ajuba LIM proteins play a role in this aspect of contact inhibition is unknown. 
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However, the Ajuba LIM proteins have been shown to interact directly with F-actin and also, to 
affect cell migration and cell spreading by activating the Rho-family GTPase, Rac (Nola et al., 
2011; Pratt et al., 2005). Thus it is plausible that, in addition to bridging cell-cell contact with 
intracellular Hippo pathway signaling, the Ajuba LIM proteins play a role in regulating YAP 
inactivation by cytoskeletal cues.  
Recently, the first extracellular circulating signal that contributes to regulation of the 
Hippo pathway, the phospholipids LPA and S1P, were identified and shown to stimulate YAP 
activity via GPCR signaling (Yu et al., 2012). This mechanism involves Lats, but seems to be 
independent of Mst1/2. Furthermore, actin cytoskeletal elements seem to mediate signaling from 
the LPA and S1P receptors to Lats1/2, since disrupting actin filaments with Latrunculin B 
abrogates the pro-proliferative effect of LPA and S1P on YAP (Yu et al., 2012). Interestingly, 
other GPCRs were shown to enhance YAP phosphorylation and inactivation, suggesting that 
GPCR signaling can regulate cell proliferation via YAP both positively and negatively, 
depending on cell type and context (Yu et al., 2012). While Ajuba LIM proteins have not been 
linked to GPCRs, they have been shown to interact with and regulate cytoskeletal components, 
suggesting that they could be involved in YAP activation by LPA and S1P.  
Alternatively, it is possible that other soluble factors could also cross-talk with the Hippo 
pathway, and the Ajuba LIM proteins could regulate those processes. For example, growth 
factors are known to regulate cell proliferation both in vivo and in vitro. Furthermore, EGFR 
signaling was shown to regulate contact inhibition downstream of NF2/Merlin. Specifically, 
NF2/Merlin is required for cell density-dependent down-regulation of EGFR signaling and 
internalization (Curto et al., 2007). Loss of NF2/Merlin results in continued EGFR activity, even 
at high density, and overgrowth (Curto et al., 2007). Interestingly, NF2/Merlin is a component of 
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the upstream Kibra/Ex/Merlin (KEM) complex which is known to activate Mst/Hippo 
(Baumgartner et al., 2010; Yu et al., 2010). However, a direct link between EGFR signaling and 
Hippo pathway activity has not yet been found. Ajuba is able to regulate growth factor signaling 
via an interaction with Grb2, which in turn results in increased activation of MAPK (Goyal et al., 
1999). It is possible that, in addition to preventing Lats activity at low density, Ajuba also 
promotes proliferative signals via growth factor signaling, and that the same mechanism that 
inactivates Ajuba-mediated Lats inhibition at high density (i.e. recruitment to adherens junctions) 
also restricts Ajuba’s pro-growth effects on MAPK activity. The restriction of EGFR signaling 
by NF2/Merlin in response to high cell density could furthermore provide an explanation for why 
contact inhibition of proliferation is partially preserved even with disruption of cell-cell contacts.  
In Drosophila, the Salt-inducible kinases (Sik2 and Sik3), which are involved in nutrient 
sensing, have recently been implicated as negative regulators of Hippo signaling (Wehr et al., 
2012). These kinases bind to and phosphorylate Sav, leading to an inhibition of the Hpo-Wts 
association and increased Yki activity (Wehr et al., 2012). These molecules represent a link 
between environmental cues (i.e. nutrient availability) and cell proliferation. It is as yet unknown 
whether this pathway is preserved in mammals and whether the Ajuba LIM proteins are involved 
in Sik-mediated Hippo regulation. However, since both Sik and the Ajuba LIM proteins function 
by modulating complex assembly, cross-talk between these two negative regulators is an 
intriguing possibility. 
Ajuba LIM proteins and the regulation of Mst activity via the Rassfs 
 In both contact inhibition of proliferation in cultured epithelial cells, and organ size 
regulation in Drosophila, we found that the Ajuba LIM proteins regulated Hippo pathway 
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signaling by enhancing complex association (Chapter 2). In doing so, they provided a link 
between cell-cell contact and the regulation of proliferation in a process dependent on their 
subcellular localization. However, in a separate mechanism of Hippo pathway regulation, we 
found that the Ajuba LIM proteins also mediated the activation of Mst2, possibly via an 
interaction with Rassf1A or Rassf6 (Chapter 4).  
The Rassf family of tumor suppressors represent some of the most frequently mutated or 
silenced genes in cancer (Avruch et al., 2006; Richter et al., 2009; van der Weyden and Adams, 
2007). They are characterized by the presence of a Ras-association (RA) domain and a C-
terminal Salvador-Rassf-Hippo (SARAH) domain, which mediates the physical interactions 
between the eponymous Hippo pathway proteins (Avruch et al., 2009). In addition, the 
mammalian Rassf proteins 1 and 5 contain a C1-type zinc finger motif, while the Drosophila 
dRassf contains a LIM domain at its N-terminus (van der Weyden and Adams, 2007). Rassf1A 
and Rassf5/Nore1 were the first Rassf family proteins to be associated with regulation of Mst1/2. 
They were found to bind to both Mst1/2 and WW45 and to enhance Mst1/2 activation (Guo et 
al., 2007; Praskova et al., 2004). Mechanistically, Rassf1A was recently shown to promote 
Mst1/2 activation by inhibiting its dephosphorylation by PP2A (Guo et al., 2011). Rassf6, on the 
other hand, inhibits Mst activation by forming a tripartite complex with WW45 and Mst (Ikeda et 
al., 2009). Functionally, a link between Rassf-mediated regulation of Mst1/2 phosphorylation 
and YAP activity has not been demonstrated. Furthermore, the role of Mst1/2 in mammalian 
Hippo pathway signaling is unclear. Several recent studies have suggested that YAP can be 
phosphorylated and inactivated in an Mst-independent manner, leaving open the possibility that 
another, as yet unknown kinase is responsible for activating Lats and/or phosphorylating YAP in 
these contexts (Dupont et al., 2011; Moleirinho et al., 2012; Schlegelmilch et al., 2011; Yu et al., 
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2012). As such, it is possible that Rassf1A-mediated activation of Mst1/2 promotes apoptosis 
and inhibits proliferation independent of YAP. Alternatively, it could indicate that the role of 
Mst1/2 in YAP regulation is constrained to specific cell types or upstream signals.  
Our finding that the Ajuba LIM proteins inhibited Mst2 activation and interacted with 
regulators of Mst activation suggested an alternate mechanism by which the Ajuba LIM proteins 
could promote cell proliferation. However, it is unclear what the physiological role of this 
regulation might be. Data suggest that Rassf1A can enhance Mst-mediated apoptosis in response 
to Ras, death receptor activation, and staurosporine (Avruch et al., 2006; Oh et al., 2006); 
however, none of these processes are thought to occur via canonical Hippo signaling. 
Nevertheless, it is possible that regulation of Mst2 phosphorylation by the Ajuba LIM proteins 
contributes to this Mst2-mediated apoptosis. Alternatively, Rassf1A, along with Mst, Lats, and 
WW45, are all associated with the mitotic apparatus, and cells deficient in Rassf1A or Lats 
display defects in mitosis (Abe et al., 2006; Guo et al., 2007; Yabuta et al., 2007). Interestingly, 
Ajuba is also recruited to centrosomes during mitosis, where it interacts with, and is 
phosphorylated by, Lats (Abe et al., 2006). The Ajuba-Lats association contributes to spindle 
formation, and depletion of either Ajuba or Lats2 causes aberrant spindle organization (Abe et 
al., 2006). Thus, it is possible that regulation of the activation of Mst2 by the Ajuba-LIM 
proteins modulates mitotic progression via the core Hippo complex components.  
It is also unclear whether such a mechanism would be conserved in Drosophila. dRassf 
does contain a LIM domain, which could mediate a physical interaction between dJub and 
dRassf. If dJub physically associates with dRassf to regulate Hippo signaling in Drosophila, it 
would almost certainly be by a novel mechanism, since its mechanism of action with regards to 
Hpo activation is not conserved in mammals (Polesello et al., 2006). Experiments in S2 cells to 
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determine whether dJub and dRassf interact, and whether such an association affects Hpo 
binding to Sav or Hpo activation would need to be conducted to address this question. 
The regulation of the Mst kinases by the Rassf proteins, and their interplay with the 
Ajuba LIM proteins, is an open area for investigation. Study of both the Rassf family and the 
Ajuba LIM family is complicated by functional redundancy between family members; however, 
understanding how these molecules interact with each other to regulate cell proliferation and 
apoptosis, in Mst-dependent or independent fashions, could further our understanding of these 
protein families in development and cancer. 
Modularity in the Hippo pathway 
A common paradigm for discussing the Hippo pathway involves the idea of protein-
protein interactions and interaction modules (Hergovich, 2012; Sudol and Harvey, 2010). For 
example, one could categorize the Hippo pathway by the types of protein interaction motifs 
involved in the association of various complexes. Within the core kinase complex, WW domain-
PPxY motif interactions underlie WW45-Lats2 and Lats2-YAP interactions (Sudol and Harvey, 
2010). Meanwhile the WW domain of the upstream regulator, Kibra, is also able to bind to the 
PPxY motif in Lats, while the downstream YAP inhibitor, AMOT, similarly interacts with YAP 
via its PPxY motif (Sudol and Harvey, 2010). The SARAH domain, another well-represented 
protein interaction module within the Hippo pathway, is implicated in the various Mst-WW45-
Rassf complexes (Hergovich, 2012). Our work, and others, has demonstrated that LIM domain-
mediated interactions may also play an important role in Hippo pathway regulation. 
We have demonstrated that the Ajuba LIM proteins function as negative regulators of 
Hippo pathway signaling. Specifically, we have found that they physically interact with Lats and 
153	  
	  
Wts and that this interaction is mediated by the LIM domains (Das Thakur et al., 2010) (Chapter 
2). Interestingly, another recent report has demonstrated that the Zyxin family of LIM proteins 
are also capable of negatively regulating the Hippo pathway in Drosophila (Rauskolb et al., 
2011). dZyx physically interacts with Wts, once again in a LIM domain-dependent fashion, and 
inhibits Wts activity by regulating its stability (Rauskolb et al., 2011). Unlike dJub, which 
mediates Lats/Wts activity through the core kinase complex, dZyx affects Wts stability through 
the Hpo-independent Ft-Dachs signaling arm (Cho et al., 2006; Rauskolb et al., 2011). Whether 
this mechanism is conserved in mammals is not known; however, the interaction between Dachs, 
a myosin protein, and Zyxin, which localizes to focal adhesions in response to high cell tension, 
suggests that the Zyxin family of LIM proteins could be involved in mechanotranduction-
mediated regulation of Yki/YAP activity (Lele et al., 2006). In addition, the parallel methods of 
Hippo pathway regulation mediated by dJub and dZyx suggest that LIM domain-containing 
proteins may represent a category of molecules whose protein-protein interactions with Hippo 
pathway components underlie more complex layers of regulation.  
The N-terminal LIM domain of dRassf has thus far not been associated with any 
particular function, and while mammalian Rassfs do not have LIM domains, the C1-type zinc 
finger motif is similar structurally and may mediate similar protein-protein interactions (van der 
Weyden and Adams, 2007). The physical association between LIMD1 and Rassf1A raises the 
tantalizing possibility that a similar interaction between dRassf and dJub may exist and define a 
novel mechanism of Hippo pathway regulation. Future experiments focusing on these 
interactions – where they occur, in response to what stimuli, and their effect on YAP/Yki activity 
– could provide further insight into the mechanisms underlying the regulation of cell 
proliferation. Furthermore, the recent discovery of several LIM domain-containing proteins as 
154	  
	  
Hippo pathway components may indicate a new category of molecules to consider in the hunt for 
novel regulators of cell proliferation. 
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